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ABSTRACT
The purpose of this research was to determine the influence of dietary Se on glutathione
peroxidase (GPx)-1 and 3 activities and relative liver GPx mRNA levels in growing Holstein bull
calves. Calves (n = 14) were started 28 d after birth on either a Se adequate (0.15 ppm Se) or
deficient (0.01 ppm Se) diet consisting of 3 growth phases and maintained on the diet until 180 d
of age. Blood samples were taken from each calf for determination of GPx-1 and GPx-3 activity.
Three calves were euthanized at d 21 of age for determination of baseline liver GPx-1 mRNA
level. Four calves from each treatment were euthanized at d 180 of age for determination of liver
GPx-1 relative mRNA level. Feed intake and average daily gain were not affected by Se level.
Mean liver Se concentration was higher (P < 0.05) for baseline calves and those fed the Se
adequate diet than for calves fed the Se-deficient diet, but there was no difference between
baseline calves and Se adequate calves with respect to liver Se concentration. The GPx-1 activity
was greater for Se adequate than Se-deficient calves (P < 0.01) but not until d 84 of age. The
GPx-3 activity was considerably more variable than that of GPx-1 with respect to the trend
observed for activity by day, and the GPx-3 activity of the Se-deficient group was only less than
that of the Se adequate group (P < 0.05) on d 180. N-fold differences were calculated for relative
GPx-1 mRNA levels between treatments. There was a 50% decrease in GPx-1 mRNA for Sedeficient calves (P < 0.05) compared with the Se adequate calves. Regression analysis also was
performed to determine the relationship between the various response variables. There was only
a moderate relationship (r2 = 0.58) between GPx-1 mRNA transcript levels and GPx-1 activity at
d 180, despite a correlation coefficient of 0.76. The relationship between GPx-1 mRNA
transcript level and GPx-3 activity at d 180 was much stronger (r2 = 0.81), with a correlation
coefficient of 0.90, which was unexpected, as GPx-3 is generally considered a short-term

xi

indicator of Se status and therefore a much more variable response. Erythrocyte GPx-1 activity
was much more sensitive to Se in the diet and thus reflected the diet more closely than did GPx3. However, GPx-3 activity was more highly correlated to GPx-1 transcript levels. These
unexpected results suggest that another trial utilizing larger sample sizes and serial sampling of
liver tissue with the sampling of plasma and erythrocytes may provide a clearer picture of the
relationship between liver GPx-1 mRNA , tissue Se concentration, and GPx enzyme activities in
neonatal and growing Holstein calves.

xii

CHAPTER I
INTRODUCTION
Selenium (Se) status is an important indicator of oxidative status and therefore health and
disease susceptibility. According to Arthur et al. (2003), “Selenium is essential for the efficient
and effective operation of many aspects of the immune system in both animals and humans.”
There is increasing evidence concerning nutritional status and immune response in mammals.
Although numerous micronutrients, including Fe, Cu, Zn, and Se, have received considerable
attention within the last decade (Failla, 2003), it is research regarding Se and immunity that has
shown promise to impact health. One of the most surprising findings is that Se deficiency in
mice promotes viral mutation and the subsequent development of virulent strains, as
demonstrated by the infection of Se-deficient mice with a normally benign virus, Coxsackie virus
B3. When Se-deficient mice were infected with Coxsackie virus, there was a significant increase
in mortality, while Se-adequate infected mice showed little to no signs of disease, thus indicating
an increase in infectivity and virulence as a result of potential genomic mutation in the
previously avirulent virus when replicated within a Se-deficient host (Beck et al., 1994a; Beck et
al., 1994b; Beck et al., 1994c). The connection between Se status and viral mutagenesis
primarily involves oxidative stress (Beck and Levander, 2000) and the role of selenium as an
antioxidant is mediated through the Se-dependant glutathione peroxidases (GPx; EC 1.11.1.9)
(Rotruck et al., 1973). These are potent antioxidant enzymes responsible for catalysis of the
reaction in which reactive oxygen species (ROS) such as hydrogen peroxide are converted to
water (Flohe, 1973). Oxidative stress, which results from a build-up of ROS, has been found to
have a considerable effect on the evolution of viruses from avirulent strains to virulent strains in
vivo, an effect that is thought to be due largely to genomic damage incurred by the virus as it is
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exposed to a highly oxidative environment (Beck and Levander, 2000). In addition, Se
deficiency has been known to have other detrimental effects on the immune system and may also
encourage the development of many pro-inflammatory compounds responsible for the
predisposition to diseases such as heart disease and cancer (Arthur et al., 2003). Selenium
deficiency is also directly linked with the development of white muscle disease and general
unthriftiness in cattle and other livestock species (Jenkins and Hidiroglu, 1986).
The potential for Se deficiency to have far reaching negative effects is considerable. An
example of this capacity lies with the negative repercussions of oxidative stress in calves, a
potentially serious problem within the livestock industry. One of the greatest health impacts of
calves during weaning, shipping, and the subsequent feedlot adjustment period is Bovine
Respiratory Disease (BRD), a disease comprised of numerous viral, bacteriological, and
mycoplasmal components (Ellis, 2001). Bovine Respiratory Disease is the most common and
economically detrimental affliction to the beef cattle industry (Snowder et al., 2006) and the
disease complex accounts for the majority of feedlot mortality (Loneragan et al., 2001). We
hypothesize that selenium deficiency-induced oxidative stress may potentiate not only an
increase in the incidence of BRD in unhealthy animals, but also in animals that were previously
in good health. Vaccination at weaning with a modified live virus is the most common method
for preventing BRD (Snowder et al., 2006) but often little or no concern is given to the selenium
status or antioxidative status of these animals at the time of vaccination. Research has shown that
protective effects of live-attenuated vaccine often depend on a number of factors, including host
nutritional status (Broome et al., 2004), thus the efficacy of such administered vaccines may be
in question. Furthermore, in vivo studies involving mice (Nelson et al., 2001) have shown that
virus replicated in Se-deficient mice results in increased morbidity and mortality when then used
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to infect healthy, Se-adequate mice. This has been hypothesized to have serious implications
when the co-mingling and transport of calves of unknown health and oxidative status is taken
into consideration.
Despite the mounting evidence linking Se deficiency to disease and disease susceptibility,
little research is available concerning the Glutathione Peroxidase activity-based categorization of
selenium status and deficiency in the postnatal and growing calf. Research has been conducted
concerning the effect of Se deficiency in young animals when exposed to agents such as Bovine
Rhinotracheitis Virus (Reffett et al., 1988) and Brucellosis vaccine in cattle (Nemec et al., 1990);
however, these studies did not attempt to categorize the extent to which these animals were made
selenium deficient. Furthermore, little information is available regarding the connection between
erythrocyte, plasma, and tissue GPx activity and liver GPx mRNA quantity in selenium deficient
versus selenium adequate calves.
The goal of this research is to provide GPx-based categorization of selenium deficiency
in postnatal calves to calves at approximately 180 days of age. The hope is that, by providing
guidelines for determining the extent of selenium deficiency based on common markers of
selenium status, future researchers may continue to further uncover the link between selenium
deficiency and disease.
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CHAPTER II
LITERATURE REVIEW
Selenium in Mammals
Selenium is considered to be an essential mineral for humans and livestock (Schwarz and
Foltz, 1957), its role being primarily in the active site of a number of catalytic enzymes including
thioredoxin reductase and the Se-dependant family of glutathione peroxidases. In humans Se
deficiency is intimately connected to Keshan disease, which results in cardiomyopathy in
affected individuals. Before discovery of the connection of Se deficiency to the disease, Keshan
disease was endemic in regions of the People’s Republic of China known to be deficient in Se
(Gu, 1983; Yang et al., 1988). Selenium deficiency in domestic livestock is expressed primarily
as white muscle disease, a debilitating affliction resulting in degeneration and necrosis of both
skeletal and cardiac muscle that affects young animals (Underwood, 1981). The resulting lesions
occur primarily as a result of oxidative damage to muscle tissue incurred when GPx activity is
limited (Gerloff, 1992). In addition, affected animals may exhibit signs of general malaise such
as weight loss that may be accompanied by diarrhea (Underwood, 1981), anemia (Morris, et al.,
1984), and a decrease in calf weaning weights (Spears et al., 1986). Selenium also has been
reported to have implications on reproductive health, as there is considerable documentation
regarding the increase of retained placenta incidence in Se-deficient dairy cattle (Harrison and
Conrad, 1984; Harrison et al., 1984). Furthermore, abortions, early embryonic death, and
infertility are all reproductive complications that have been attributed to Se deficiency (Maas,
1983). Selenium also plays an integral role in the immune system and has been associated with
increased intracellular kill of S. aureus and E. coli by bovine neutrophils (Gyang et al., 1984;
Grasso et al., 1990). In cows supplemented with 0.3 ppm Se, intracellular kill of E. coli and S.
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aureus was increased in neutrophils, compared with cows that were not supplemented with Se
(Hogan et al., 1990). Some studies have even suggested the involvement of Se in both murine
(Arthur et al., 2003) and ruminant antibody production and lymphocyte function (Larsen et al.,
1988; Reffett et al., 1988). The subclinical effects observed in ruminants involving lymphocyte
function and antibody production have been suggested to be mediated via the activity of GPx
and, according to Baboir (1984), polymorphonuclear leukocytes are highly sensitive to oxidative
damage, due primarily to their use of “oxidative bursts” in intracellular killing.
Selenium absorption occurs primarily in the duodenum with very little absorption by the
rumen or abomasum (Wright and Bell, 1966). From the duodenum, Se is carried in the blood to
the liver either via carrier proteins or in the free form, where it is then incorporated into
selenoproteins, the translation of which is determined genetically (Surai, 2006). While urinary
excretion is the primary mode of Se regulation in most non-ruminants, the primary site for
excretion of orally administered Se in the ruminant is via the feces. However, when Se is
administered either subcutaneously or intravenously, urinary excretion tends to increase versus
fecal excretion. In addition, it has been shown that lambs maintained on milk have higher urinary
excretion of orally administered Se before rumen development, but that fecal excretion increases
as rumen development progresses (Miller and Ramsey, 1988).
The Se requirement for beef cattle is 0.1 ppm, with a maximum tolerable intake of 2.00
ppm (NRC, 2001). Toxicity may occur when extremely high levels of Se are consumed or when
moderately high levels are consumed over an extended period of time. Acute Se toxicity
primarily occurs most often with the ingestion of plants that have a high affinity for and tend to
accumulate Se, but may occur when animals are over-supplemented with Se. When large
amounts of these seleniferous plants are consumed, acute toxicity symptoms are usually severe
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and include a stifled gait, drooped ears, and lowered head. In addition, animals may exhibit high
body temperature, diarrhea, elevated but weak pulse, and labored respiration. If left untreated,
acute toxicity may lead to death (Miller and Ramsey, 1988). Chronic toxicity, or alkali disease,
can occur when livestock graze cereals, grasses, or hays containing 5 to 50 ppm Se for an
extended period of time. Symptoms generally consist of hair loss and sloughing of the hooves.
The condition is also characterized by anemia, reduced fertility, stiffness of the joints, and
painful hoof lesions (Miller and Ramsey, 1988). While Se toxicity is a concern, Se deficiency is
also an important consideration, as previously discussed. Morris et al. (1984), Hidiroglu et al.
(1985), and Spears et al. (1986) have reported either clinical or subclinical Se-deficiency in cattle
grazing forages containing 0.02 or 0.05 mg/kg Se, although there are reports of calves
consuming semi-purified diets containing only approximately 0.02 ppm selenium with no
observed clinical signs of deficiency (Reffett et al. 1988; Boyne and Arthur, 1981).
Determining Se Status
Since the discovery by Schwarz and Foltz (1957) that Se was an essential dietary trace
element, researchers have been looking for the most accurate and precise method of determining
Se status, both in humans and animals. Numerous methods of determining Se status are
commonly utilized by laboratories, including determination of serum or plasma Se, whole blood
Se, liver and other tissue Se, and erythrocyte and plasma glutathione peroxidase activity (Gerloff,
1992). However, it is these various approaches to assessing Se status that contribute to some
confusion in the scientific community concerning exactly what adequate Se status entails. In
addition, reports from various labs tend to deviate considerably (Ullrey, 1987), making the task
of comparing results between labs difficult. Furthermore, it is somewhat difficult to find research
correlating specific experimental results such as tissue, plasma, or whole blood Se concentration
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to incidents of Se-deficiency induced diseases like white muscle disease (Gerloff, 1992). As a
result, most reports contain data from multiple indicators of Se status and there has been recent
focus on correlating such indicators to one another.
Se Concentration in Tissues
One of the most commonly considered assessments of Se status involves concentration of
the trace mineral in the body tissues. Tissue Se concentration can be expected to vary with the
amount and chemical form of Se in the diet, and in most cases rise with increased Se intake, but
not all tissues accrue Se equally (Ullrey, 1987). A study performed by Behne and Wolters (1983)
in which rats were fed a commercial diet containing 0.3 ppm Se reported that Se concentrations
in tissue, on a wet basis, ranked from highest concentration to lowest in the order of kidney,
liver, testes, adrenals, erythrocytes, spleen, pancreas, plasma, lungs, heart, thymus, skeletal
muscle, and brain. Studies in cattle of various ages have found that tissue Se concentration
declines in order of kidney to liver, heart, and skeletal muscle (Maag and Glen, 1967; Kincaid et
al., 1977; Ullrey et al., 1977; Ammerman et al., 1980). In the study reported by Behne and
Wolters (1983), Se concentrations in the liver, kidney, erythrocytes, and plasma of rats was 1.29,
1.45, 0.52, and 0.42 ppm Se, respectively (Table 2.1). Assessment of Se status has been
performed extensively in various species, including the rat, pig, sheep, chicken, and cow.
Whanger and Butler (1988) conducted a trial with male weanling Sprague-Dawley rats in which
they fed the rats increasing levels of Se supplemented to a basal diet containing 0.02 ppm. The
diets were formulated to contain 0.2, 1.0, 2.0, or 4.0 ppm Se. The researchers found that the rats
consuming the basal diet had whole blood, liver, and kidney Se concentrations of 0.03 ± 0.01,
0.02 ± 0.00, and 0.22 ± 0.08 µg Se/g tissue (wet weight), respectively. Rats consuming diets
supplemented with 0.2 ppm Se as sodium selenite had whole blood, liver, and kidney Se

7

concentrations of 0.50 ± 0.06, 0.72 ± 0.05, and 1.07 ± 0.06 µg Se/g (wet weight), respectively.
Rats consuming diets supplemented with 1.0 ppm Se as sodium selenite had whole blood, liver,
and kidney Se concentrations of 0.60 ± 0.04, 0.90 ± 0.10, and 1.53 ± 0.13 µg Se/g (wet weight),
respectively (Table 2.1). A study was performed by Weiss et al. (1996) in which female rats
were fed either a basal diet containing 0.007 ppm Se or a diet supplemented with 0.02, 0.05, 0.1,
0.15, 0.2, or 0.3 ppm Se. The researchers reported that supplementation with 0.02 ppm Se did not
significantly increase the liver Se concentration above those rats fed the basal diet and that the
liver Se concentration of rats fed the Se-deficient basal diet was 4% the concentration in rats fed
the 0.1 ppm diet, on average. Furthermore, liver Se concentration increased sigmoidally with
increasing dietary Se.
Swine studies have shown a similar trend regarding Se concentration in body tissues. A
study performed by Mahan et al. (1999) was conducted to examine the effect of dietary Se level
and source, either organic Se as SeMet or inorganic Se fed as sodium selenite, on tissue Se and
various other response variables of grower-finisher pigs. The pigs were bled at trial onset and
then at intervals of 30, 60, and 90-d after trial initiation. In the study, the researchers found that
swine fed the basal diet containing an average of 0.06 ppm Se had serum Se concentrations of
0.080 ppm at d 0 and then of 0.053, 0.057, and 0.063 on d 30, 60, and 90 of the trial,
respectively. Groups of pigs were also supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se as
sodium selenite in addition to the basal diet. No d 0 serum sample was taken for these pigs, but
pigs were sampled for serum Se on d 30, 60, and 90 of the trial. On d 30 of the trial, serum Se
concentrations for the pigs fed a diet supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se were
0.098, 0.128, 0.121, and 0.137, respectively. Serum Se concentrations for the same pigs on d 90
of the trial were 0.120, 0.133, 0.139, and 0.152, respectively. When researchers examined liver
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Table 2.1. Se Concentrations [Se] in Various Tissues of Rats.

Author
Behne and
Wolters
Whanger
and Butler
Whanger
and Butler
Whanger
and Butler
a
Whole blood.

Year

[Se] in
Diet
(ppm)

[Se] in Liver

[Se] in
Kidney
(ppm)

[Se] in RBC

[Se] in
Plasma
0.42

1983

0.3

1.29

1.45

0.52

1988

Basal
(0.02)

0.02 ± 0.00

0.22 ± 0.08

0.03±0.01a

-

1988

0.2

0.72 ± 0.05

1.07 ± 0.06

0.50 ± 0.06a

-

1988

1.0

0.9 ± 0.10

1.53 ± 0.13

0.60 ± 0.04a

-

from a subset of these groups at 55 kg body weight they reported liver Se concentrations of
0.195, 0.425, 0.464, 0.526, and 0.522 ppm for pigs fed either the basal diet or a diet
supplemented with 0.05, 0.10, 0.20, or 0.30 ppm Se, respectively. Pigs at 55 kg of body weight
were also examined for kidney Se concentrations. When fed either the basal diet containing no
added Se or the diets containing 0.05, 0.10, or 0.30 ppm Se, the kidney Se concentrations were
1.305, 1.716, 1.771, and 1.655 ppm Se, respectively. A subset of pigs weighing 105 kg was also
killed in order to determine both liver and kidney Se concentration. Pigs fed either the basal diet
containing no added Se or the basal diet containing 0.05, 0.10, or 0.30 ppm supplemental Se had
liver Se concentrations of 0.258, 0.452, 0.436, and 0.534 ppm Se, respectively. The kidney Se
concentrations of the same pigs were 1.811, 2.283, 2.333, 2.328, and 2.376 ppm Se, respectively
(Table 2.2). A study performed by Lei et al. (1998) found that plasma Se concentrations for pigs
fed a basal diet containing 0.03 ppm Se were 1.25 at d 0 of the trial and 0.18 ppm Se at d 35.
Plasma Se concentrations increased in pigs with increasing level of Se supplementation, either
the basal and 0.1 ppm Se, or the basal with 0.3 ppm Se added. The plasma Se concentration at d
35 in pigs fed the basal diet supplemented with 0.1 or 0.3 ppm Se were 0.84 and 1.62 ppm Se,
respectively. The second experiment reported in the study found that pigs fed a basal diet

9

containing 0.042 ppm Se had plasma Se concentrations on d 0 of 0.26, 0.24, and 0.23 ppm Se,
respectively, while the same pigs at d 35 had plasma Se concentrations of 0.46, 0.49, and 0.58
ppm Se, respectively. The results of both Lei et al. (1998) and Mahan et al. (1999) supported
earlier findings by Groce (1973) and Lowry (1985a, b) (Table 2.2).
Table 2.2. Se Concentrations [Se] in Various Tissues of Pigs.

Author
Groce et al.
Lowry et
al.
Lowry et
al.
Lei et al.
Lei et al.
Lei et al.

0.15

[Se] in
Liver
(ppm)
0.57

[Se] in
Kidney
(ppm)
2.06

8 wk

0.35

0.49

1.36

8 wk

0.35

0.50

1.42

-

-

-

-

-

-

0.195

1.305

0.425

1.716

0.464

1.771

0.522

1.655

0.258

1.811

0.452

2.283

0.436

2.333

0.534

2.376

Year/Exp

Weight/
Age

[Se] in
Diet (ppm)

1971

25 wk

1985a
1985b
1998, Exp
1
1998, Exp
1
1998, Exp
1

Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
Mahan et
1999
al.
a
sampled on d 35 of trial.

9 wk
9 wk
9wk
55 kg
55 kg
55 kg
55 kg
105 kg
105 kg
105 kg
105 kg

Basal
(0.03)
Basal +
0.1
Basal +
0.3
Basal
(0.06)
Basal +
0.05
Basal +
0.10
Basal +
0.30
Basal
(0.06)
Basal +
0.05
Basal +
0.10
Basal +
0.30

[Se] in
Plasma
(ppm)
0.18a
0.84a
1.62a
-

Numerous studies have also been performed to assess the effect of Se supplementation on
tissue Se concentration in cattle. Maag and Glen (1967) reported that 12 month old steers
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consuming 0.11 ppm Se in an unsupplemented diet had kidney and liver Se concentrations of
1.08 to 1.32 ppm and 1.13 to 1.20 ppm, respectively (Table 2.3). Kincaid et al. (1977) found that
one month old calves consuming 0.3 ppm Se in an unsupplemented diet had kidney and liver Se
concentrations of 2.70 and 0.91 ppm, respectively. In addition, a study performed by Ullrey et al.
(1977) in which 15 to 18 month old steers were fed a diet containing approximately 0.18 ppm Se
found the animals to have kidney and liver Se concentrations of 1.37 and 0.38, respectively
(Table 2.3). A study was also performed by Awadeh et al. (1998) in which growing Holstein
heifers were fed either 0.41 or 0.73 ppm Se from 92 ± 7 d of age until approximately 180 d of
age. Heifers fed the adequate diet (0.41 ppm Se) had a mean serum Se concentration of 0.115
ppm. Calves fed the excessive diet (0.73 ppm Se) had a serum Se concentration of 0.287 ppm.
The same group performed another study in which pregnant, adult crossbred beef cows were fed
one of three experimental mineral premixes designed to contain 20, 60, or 120 ppm Se as sodium
selenite. The estimated intakes of the three mineral salts were 2.4, 4.7, and 8.7 mg Se/d,
respectively. Cows consuming the mineral salt containing 20 ppm Se were found to have a whole
blood Se concentration of 0.110 ppm. The same cows were found to have an average serum Se
concentration of 0.491 ppm, indicating that over 50% of the Se in the whole blood of those cows
was contained in the cellular fraction, most likely in the erythrocytes. Cows consuming mineral
premixes containing 60 or 90 ppm had whole blood Se concentrations of 0.154 and 0.192 ppm,
respectively, and serum Se concentrations of 0.86 and 0.81 ppm, respectively. Rowntree et al.
(2004) reported average plasma selenium concentrations for selenium-drenched pregnant, adult
cows that ranged between 0.970 ppm and 0.619 ppm, depending on the time of year. In this
study, cows sampled in May had the highest plasma selenium concentrations and when sampled
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in September had an average plasma selenium concentration of 0.619 ppm. (SEM=4.61), over
0.30 ppm less than when sampled in May (2004) (Table 2.3).
Table 2.3. Se Concentrations [Se] in Various Tissues of Cattle.
Author

Year

Age

[Se] in
Diet, ppm

[Se] in
Liver,
ppm
1.13 to
1.20
0.91

[Se] in
Kidney,
ppm
1.08 to
1.32
2.70

[Se] in
Plasma,
ppm

Maag and
1967
12 mo old
0.11
Glen
steers
Kincaid et
1977
1 mo old
0.30
al.
calves
Ullrey et
1977
15 – 18 mo
0.18
0.38
1.37
al.
old steers
Awadeh et
1998
~ 180 d old
0.41
0.115a
al.
heifers
Awadeh et
1998
~ 180 d old
0.73
0.287a
al.
heifers
Awadeh et
1998
Pregnant,
20c
0.049a
b
al.
adult cows
Awadeh et
1998
Pregnant,
60d
0.154a
b
al.
adult cows
Rowntree
2004
Pregnant,
20 mg,
0.061
et al.
adult cows
daily
to 0.097
Rowntree
2004
Neonatal
1 mgf
0.072
et al.
heiferse
1 mgf
Rowntree
2004
Neonatal
0.119
et al.
heifersg
1 mgf
Rowntree
2004
Neonatal
0.089
et al.
heifersh
a
Concentration of Se in serum.
b
90 d prepartum to 3 mos postpartum.
c
Concentration of Se in a supplemental salt. Estimated daily intake per cow was 2.4 mg/d.
d
Concentration of Se in a supplemental salt. Estimated daily intake per cow was 4.7 mg/d.
e
d 0 of age.
f
one-time injection, immediately after birth.
g
d 1 of age.
h
d 6 of age.
Often of interest is the effect of cow Se status on Se concentrations in the tissues of
neonatal and growing calves, because it has been shown that Se effectively passes through the
placental barrier in cattle (Van Saun et al., 1989). Early signs of Se-deficiency as well as other
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mineral deficiencies in ruminants are often expressed in the young of deficient animals as, in the
case of Se, white muscle disease or neonatal ataxia (Abdelrahman and Kincaid, 1993).
Therefore, tissue reserves of such nutrients in the fetal and neonatal calf are of considerable
interest. Abdelrahman and Kincaid (1993) measured liver Se concentration in fetuses of various
ages removed from cows at slaughter and found that, on average, Se concentration increased
from d 145 to d 195, but then decreased from d 195 to d 245. The researchers concluded that this
decrease in liver Se concentration during late gestation might possibly reflect an increase in the
synthesis of selenoproteins such as GPx by the fetus prepartum, and therefore an increased need
for Se by the fetus. A study performed by Weiss et al. (1984) found that Holstein calves from
cows fed 0, 1, or 5 mg of supplemental Se as sodium selenite 60 d before parturition had serum
Se concentrations that mirrored that of their respective dams. When the serum Se concentrations
of calves at birth were regressed against serum Se concentrations of their dams at 60 d
prepartum, or d 0 of the trial, there was virtually no correlation (r2 = 0.01). However, when the
serum Se concentrations of the same calves were then regressed on the serum Se concentrations
of their dams at 45, 30, 15, and 0 d prepartum, there was significant correlation (r2 = 0.79, 0.79,
0.83, and 0.73, respectively). Furthermore, calves whose dams received 1 mg supplemental Se
maintained higher serum Se concentration longer than those calves whose dams received no
supplemental Se. The researchers interpreted this data to suggest that Se concentration in the
blood of prepartum cows can be used to predict neonatal calf Se status and that supplementation
of the dam may be a method of increasing calf Se concentrations before parturition. In addition,
cow Se status may also continue to play a significant role in the Se status of their calves after
parturition, primarily if calves continue to suckle cows, as occurs in beef cattle, since Se is also
transferred through the milk of lactating females (Rowntree et al., 2004; Bruzelius et al., 2007).
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Ammerman et al. (1980) reported that kidney and liver Se concentrations of calves suckling
cows maintained on a diet consisting of approximately 0.2 ppm Se (0.1 ppm occurring naturally
and 0.1 ppm supplemented Se) and having an average liver Se concentration of 0.2 ppm were
1.22 and 0.11 ppm, respectively.
Given the wide range of Se concentrations and the considerable amount of variability
between different laboratories, some researchers have attempted to provide ranges of Se
concentrations for use as a Se status guideline. In the review titled “Biochemical and
Physiological Indicators of Selenium Status in Animals” (1987), Ullrey states that plasma Se
concentrations of 0.08 to 0.12 ppm may be considered adequate. The Michigan State University
Animal Health Diagnostic Laboratory has also attempted to provide such ranges for reference.
According to their laboratory, normal plasma selenium concentrations for adult cattle are
expected to range from 0.070 to 0.100 ppm and serum selenium values generally increase
gradually as animals age, with initial serum selenium values of approximately 0.050 to 0.080
ppm for neonates considered normal (Stowe and Herdt, 1992). The Michigan State University
Animal Health Diagnostic Laboratory analyzed serum samples for cattle of various ages and
found that, on average, young calves aged 10 to 29 days of age had serum selenium
concentrations between 0.055 and 0.075 ppm, and between days 30 and 180 of age, calves
typically had serum selenium concentrations between 0.060 and 0.080 ppm (Stowe and Herdt,
1992). According to Gerloff (1992), marginally Se-deficient adult cattle generally have plasma
selenium concentrations between 0.040 and 0.070 ppm, while adult cattle with concentrations
below 0.040 ppm are considered deficient. Liver selenium concentrations generally range
between 1.2 and 2.0 ppm on a dry weight basis and are typically consistent in normal animals of
adequate selenium status, regardless of animal age (Stowe and Herdt, 1992).
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Although plasma, whole blood, and tissue selenium concentrations are commonly
measured, these response variables are not generally recognized as being accurate indicators of
selenium status (Gerloff, 1992). This is primarily due to the fact that Se may be absorbed in one
of two forms, inorganic, usually as sodium selenite, or in the organic form, most commonly as
selenomethionine (SeMet), which is incorporated nonspecifically into protein as an amino acid in
which the sulfur residue has been replaced by Se. Selenomethionine is not incorporated into Sedependent GPx, considered to be one of the most common functional forms of Se, thus assay for
Se in whole blood, serum, plasma, or other tissues alone may not provide an accurate depiction
of functional Se status (Burk, 1991). In fact, an increase in tissue Se concentration is not always
associated with a corresponding increase in GPx activity (Lane et al., 1979; Elsey et al., 1983;
Whanger and Butler, 1988). In addition, when serum Se concentration was regressed via simple
linear regression on whole blood Se concentration, the correlation coefficients were moderately
high (r2=0.62 and 0.88 for HG-AAS data and ICP data, respectively). However, prediction
intervals calculated from these correlation coefficients for estimating whole blood Se from serum
Se were very wide (Maas, 1992). For this reason, most conclude that serum Se concentration is
not necessarily an appropriate indicator of nutritional Se status. The researchers theorized that
these wide intervals were possibly due to short-term changes in serum Se concentration due to
variable Se intake short-term, whereas whole blood, or erythrocyte, Se concentration reflects
more long-term Se status (Maas, 1992). Given these drawbacks to the sole use of Se
concentration as an indicator of Se status, GPx activity is generally considered a more accurate
indicator of Se status, but not all forms of the enzyme serve equally in this role.
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The Se-Dependent Glutathione Peroxidases
The role of Se in the body is primarily as an antioxidant via the Se-dependent glutathione
peroxidases (Arthur et al., 2003). Using erythrocytes extracted from rats maintained on either a
Se-adequate or Se-deficient diet, Rotruck et al. (1973) found that hemoglobin oxidation was
increased in the erythrocytes of rats maintained on the Se-deficient diet. Further investigation by
the group showed that Se was a “necessary and integral” part of the GPx enzyme. In addition,
Flohe et al. (1973) showed that the GPx enzymes contained 4 g atoms of Se mol-1. Since the
discovery of Se in the active site of GPx by Rotruck et al. (1973) and Flohe et al. (1973), four
primary Se-dependent GPx enzymes have been identified: Classical Glutathione Peroxidase
(GPx-1; EC 1.11.1.9), Gastrointestinal Glutathione Peroxidase (GPx-2; 1.11.1.9), Plasma
Glutathione Peroxidase (GPx-3; 1.11.1.9), and Phospholipid Hydroperoxide Glutathione
Peroxidase (GPx-4; EC 1.11.1.2). Each of the Se-dependent GPx enzymes, with the exception of
GPx-4 (Lei et al., 1995), is a homotetramer (Takahashi et al., 1987) containing one
selenocysteine per subunit in the active site of the enzyme (Forstrom et al., 1978) and each
subunit has a molecular mass of approximately 19 kD (Epp et al., 1983). The primary function of
the GPx enzyme is as an antioxidant responsible for catalysis of the reaction in which glutathione
(GSH) in the reduced form is used to reduce cellular reactive oxygen species (ROS), primarily
hydrogen peroxide (H2O2), common byproducts of cellular metabolism and processes involving
oxygen (Flohe, 1973). These strong oxidants have the potential to react with cellular
macromolecules and cause damage such as genomic mutations, destruction of protein structure
and function, and lipid peroxidation, which may, in turn, result in considerable cellular oxidative
stress and even cell death (Halliwell et al., 1992; Poot, 1991). In order to avoid such damage,
these ROS are converted to water (H2O) or, in the case of organic hydroperoxides, non-toxic
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alcohols. Nictotinamide Adenine Dinucleotide Phosphate (NADPH) then serves as a hydrogen
donor to the oxidized GSH, returning it to the active reduced form. Specifically, two glutathione
molecules are oxidized to form two molecules of water from one molecule of H2O2 via the
catalytic enzyme GPx. The oxidized glutathione (GSSG) is then reduced via catalysis by the
enzyme glutathione reductase (GSSG-R) to reform two molecules of glutathione (Paglia and
Valentine, 1967) (Figure 2.1).
2 GSH + H2O2 ----GPx----Æ 2 H2O + GSSG + NADPH --GSSG-R--Æ 2 GSH + NADP-.
Figure 2.1. The oxidation and subsequent reduction of GSH, from Paglia and Valentine (1967).
Glutathione Peroxidase-1 (GPx-1)
Since the discovery (Mills, 1957) and partial purification (Mills, 1959) of GPx, numerous
forms of the enzyme have been isolated and purified in various body tissues. The form of GPx
contained within the cell cytosol and mitochondria is GPx-1, or cytosolic GPx (Chambers et al.,
1986; Esworthy et al., 1997). The highest activity of this enzyme is generally considered to be in
the liver, followed by the erythrocytes, lungs, and heart (Ullrey, 1987). Considerable research
has shown that GPx-1 functions primarily in an anti-oxidant role, its primary substrate being
H2O2 and other organic hydroperoxides. Using GPx knockout mice possessing a homozygous
null mutation for GPx-1, Haan et al. (1998) demonstrated that the enzyme has a significant role
in the protection of cells from paraquat-induced oxidation. The GPx-1 knockout mice were
shown to have significantly increased mortality when exposed to 30 ppm paraquat, with 100% of
knockouts dying within 5 hours of exposure, versus the controls, which showed no evidence of
toxicity. The group also showed that cortical neurons, when challenged directly with H2O2, were
considerably more susceptible to oxidative damage in the knockout mice than in the control
group. Furthermore, Haan et al. (1998) showed that exposure to paraquat transcriptionally up-
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regulated GPx-1 in normal cells, reinforcing the importance of the enzyme in protection from
oxidative stress. Recent studies utilizing GPx-1 knockout mice also have shown that these
animals are actually healthy and fertile up to 15 month of age, showing no considerable growth
response which may be attributed to Se-deficiency or, as a result, GPx-1 deficiency (Ho et al.,
1997; Cheng et al., 1997). These findings agree with other observations using Se-deficiency to
induce a decrease in GPx activity in various species (Christiansen and Burgener, 1992; Lei et al.,
1995; Mahan and Parrett, 1996; Weiss et al., 1996; Lei et al., 1998; Haan et al., 1998; Lawler et
al., 2004; Payne and Southern, 2005). These reports are in conflict with findings of Whanger and
Butler (1988) in which rats fed a basal diet containing 0.02 ppm Se gained significantly less than
those rats fed a diet supplemented with varying levels of Se. However, the researchers reported
that the rats consuming the basal diet consumed significantly less feed than those rats fed the
basal diet supplemented with varying levels of Se.
Glutathione Peroxidase activity in blood is associated largely with erythrocytes, which
contain approximately 98% of total GPx-1 activity (Scholtz and Hutchinson, 1979). The enzyme
is incorporated into reticulocytes, the precursors of erythrocytes, during their formation with
whole-body erythrocyte turnover only occurring approximately every 90 to 120 days in the
bovine (Ullrey, 1987), marking erythrocyte GPx-1 (RBC-GPx) activity as an ideal estimator of
long-term Se status. However, there are notable inter-species variations with regard to GPx
activity in erythrocytes. A comparison of GPx activity in nine species was published by Suzuki
et al. (1985). The means of the nine species ranged from 22 EU/g hemoglobin (Hb) in the golden
hamster to 493 EU/g Hb in the mouse, where one enzyme unit (EU) is equal to the amount of
GPx activity required to oxidize 1 µmol NADPH per min. The GPx activity in the erythrocytes
of cattle was reported to be 165 ± 43 EU/g Hb (Suzuki et al., 1985) (Table 2.4). A study
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performed by Whanger and Butler (1988) found that rats fed a basal diet containing 0.02 ppm Se
had an average RBC-GPx activity of 47 ± 11 EU/g Hb. When rats were fed the basal diet
supplemented with 0.2 ppm Se or 1.0 ppm Se a sodium selenite, they had an average RBC-GPx
activity of 435 ± 19 EU/g Hb and 518 ± 21 EU/g Hb, respectively (Table 2.5). Weiss et al.
(1996) found that RBC-GPx activity in Se-deficient rats maintained on a diet containing 0.007
ppm Se was 40 ± 3% of the activity in Se adequate female rats fed a diet containing 0.1 ppm Se
as sodium selenite. Erythrocyte GPx-1 activity ranged from approximately 80 EU/ g Hb for rats
consuming the Se-deficient basal diet containing 0.007 ppm Se to approximately 280 EU/g Hb
for those rats fed a diet supplemented with 0.3 ppm Se as sodium selenite (Table 2.5).
Erythrocyte GPx-1 activity has also been used as an indicator of Se status in cattle at
various production stages. In a study examining the effect of pre- and post-partum Se
supplementation on cows and their calves, cows consuming 13 mg Se/d for 15 d pre-partum had
an average d 0 RBC-GPx activity of 2.33 EU/g Hb. When sampled at 15 and approximately 54 d
post-partum, the same cows had an average RBC-GPx activity of 122.4 EU/g Hb and 127.2 EU/g
Hb at respectively. Calves from these cows had RBC-GPx activity of 186.2 and 129.3 EU/g Hb
at 15 d and 54 d post-partum, respectively. In the same study, cows consuming 32.5 mg Se/d had
an initial RBC-GPx activity of 1.67 EU/g Hb. When these cows were sampled at d 15 and 54
post-partum, they had an average RBC-GPx activity of 161.7 and 181.1 EU/g Hb, respectively
(Enjalbert et al., 1999). A second experiment conducted by the same group found that when
cows were supplemented with 0, 13, or 32.5 mg Se/d for 15 d postpartum and sampled
approximately 101 d post-partum, they had an average RBC-GPx activity of 67.2, 146.4, and
150.9 EU/g Hb, respectively (Table 2.5). The calves of the same cows were treated with 1.38 mg
Se intramuscularly on d 2 post-partum and again at approximately 49 d of age. When these
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calves were sampled at approximately 101 d post-partum, they had an average RBC-GPx activity
of 130.0, 156.4, and 177.1 EU/g Hb when their dams received 0, 13, or 32.5 mg Se/d,
respectively (Enjalbert, 1999). In a study conducted by Rowntree et al. in 2004 involving
Table 2.4. Average RBC-GPx-1 Activity of Animals and Humans, from Suzuki et al., 1985.
EU/g Hba,b

Species
Golden hamster

22 ± 2

Guinea Pig

28 ± 6

Rabbit

33 ± 7

Rat

106 ± 20

Mouse

493 ± 124

Goat

115 ± 53

Sheep

124 ± 41

Cattle

165 ± 43

Human

35 ± 7

a

Mean ± 95% confidence limits.
EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per
min.

b

multiparous Hereford cows, erythrocyte GPx activities in cows unsupplemented with Se were
14.94 EU/g Hb, while RBC-GPx activity in cows supplemented with Se was 24.61 EU/g Hb
(SEM=3.33).
Glutathione Peroxidase-1 is also found in animal tissues, most notably the liver, lungs,
and heart (Ullrey, 1987). It is often desirable to examine GPx-1 activity in tissues in an attempt
to both accurately determine Se status and to correlate tissue activity to tissue Se concentrations
and GPx-1 mRNA concentrations. Liver is often used for this purpose as it has been shown to
have the highest GPx activity of any tissue that has been analyzed (Behne and Wolters, 1983).
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Knowles et al. (1999) reported that liver GPx-1 activity was positively correlated to both liver Se
concentration (r2= 0.73) and, to a lesser extent, blood Se concentration (r2= 0.69). Liver GPx-1
activity is also highly responsive to Se status. Liver GPx activity in Se-deficient rats has been
Table 2.5. Erythrocyte GPx-1 activity in various species fed varying levels of Se.
Year

Species

[Se] in diet,
ppm

1988

Rat

0.02

47 ± 11

1988

Rat

0.2

435 ± 19

1988

Rat

1.0

518 ± 21

Weiss et al.

1996

Rat

0.007

Weiss et al.

1996

Rat

0.3

Enjalbert et al.

1999

Cow

10b,c

67.2d

Enjalbert et al.

1999

Cow

13b

146.4d

Enjalbert et al.

1999

Cow

32.5b

150.9d

Rowntree et al.

2004

Cow

No supplemental

14.94

Rowntree et al.

2004

Cow

20 mg drench

24.61

Author
Whanger and
Butler
Whanger and
Butler
Whanger and
Butler

RBC-GPx-1,
EU/g Hba

80
280

a

EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per
min.
b
mg Se d-1.
c
supplemented for 15 d postpartum.
d
at 101 d post-partum.
previously reported to be as little as 8% of that observed in rats maintained on a Se-adequate diet
formulated to contain 0.5 ppm Se (Lawrence and Burk, 1976). Whanger and Butler (1988) found
that rats maintained on a Se-deficient basal diet containing 0.02 ppm Se had an average liver
GPx activity of 8 ± 4 EU/g protein, while rats fed the basal diet supplemented with 0.2 ppm Se
as sodium selenite had an average liver GPx activity of 700 ± 105 EU/g protein (Table 2.6).
Weiss et al. (1996) reported average liver GPx-1 activity of rats consuming a basal diet
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containing 0.007 ppm Se to be less than 100 EU/g protein, only 2% of the activity observed in
rats fed a diet containing 0.1 ppm Se as sodium selenite. In this study, the liver GPx activity of
the supplemented rats was, on average, approximately 2,400 EU/g protein (Table 2.6). Liver
GPx-1 activity levels have also been determined in swine; growing pigs maintained on a Sedeficient basal diet containing 0.03 ppm Se were found to have an average liver GPx-1 activity
of approximately 12.5 EU/g protein, while pigs fed the basal diet supplemented with either 0.1 or
0.3 ppm Se as sodium selenite had average liver GPx-1 activities of 50 and 210 EU/g protein,
respectively (Lei et al., 1998, Table 2.6).
Table 2.6. Liver GPx-1 activity in various species fed varying levels of Se.
Year

Species

[Se] in diet,
ppm

1988

Rat

0.02

8±4

1988

Rat

0.2

700 ± 105

Weiss et al.

1996

Rat

0.007

Weiss et al.

1996

Rat

0.1

Lei et al.

1998

Pig

0.03

12.5

Lei et al.

1998

Pig

0.1

50

Lei et al.

1998

Pig

0.3

210

Author
Whanger and
Butler
Whanger and
Butler

Liver GPx-1,
EU/g protein

< 100
2,400

Glutathione Peroxidase-3 (GPx-3)
In comparison to that of erythrocytes, plasma Se levels are more sensitive to short-term
changes in Se supplementation and tend to fluxuate depending on Se concentration, frequency of
Se intake, and even hydration status. Thus, extracellular plasma GPx-3 activity is considered to
reflect short-term Se status and is considered inappropriate as a long-term indicator of Se status
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(Gerloff, 1992). Since its discovery in 1986 (Takahashi and Cohen), research has shown that
GPx-3 is actually regulated separately from GPx-1, illustrated in part by research showing that
Se repletion results in an increase in GPx activity at different times for erythrocytes versus
plasma. Plasma GPx activity increases relatively quickly in comparison to the rate of increase of
RBC-GPx activity, for which there is a significant lag-time of approximately four to five weeks
in humans. This lag is due to the fact that GPx-1 may only be incorporated into the erythrocyte
during erythropoiesis (Cohen et al., 1985). An additional experiment in which rats both
genetically altered to overexpress GPx-1 and GPx-1-normal rats were fed either a diet adequate
or deficient in Se further supports the work of Cohen et al. (1985). In this experiment, the
overexpression of GPx-1 failed to have any bearing on the expression of GPx-3 (Cheng et al.,
1997). In addition, when GPx-1 knockout mice were fed one of two diets containing either 0.002
ppm Se or 0.5 ppm supplemented Se as sodium selenite, researchers observed no effect of the
knockout of the GPx-1 gene on GPx-3 activity or GPx-3 mRNA expression in the kidney (Cheng
et al., 1997). Whereas the primary site of GPx-1 synthesis is the liver, the primary site of GPx-3
mRNA and protein synthesis is the proximal tubules of the kidney (Avissar et al., 1994).
Furthermore, sequencing of the purified protein (Esworthy et al., 1991) and its cDNA (Takahashi
et al., 1990) have demonstrated that GPx-3 is a separate gene product from that of GPx-1, in
spite of previous belief that the two resulted from post-transcriptional modification of the same
gene.
As with tissue Se concentration and GPx-1 activity, there is considerable inter-species
and inter-lab variation with respect to reported activity (Ullrey, 1987). Lei et al. (1995) found
that rats fed a basal diet containing 0.002 ppm Se had an average GPx-3 activity of 2.00 ± 0.58
EU/g protein, while rats fed a diet supplemented with 0.130 ppm Se as sodium selenite had an
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average GPx-3 activity of 95.33 ± 14.15 EU/g protein (Table 2.7). Weiss et al. (1996) found that
plasma GPx-3 activity in rats fed a Se-deficient basal diet was 8 ± 1% that of rats fed a diet
supplemented with 0.1 ppm Se as sodium selenite. Plasma GPx-3 activity for the deficient rats
was approximately 1.0 EU/g protein while activity for rats maintained on a diet supplemented
with 0.1 ppm of diet was approximately 800.0 EU/g protein (Table 2.7). Research with swine has
Table 2.7. GPx-3 activity in various species fed varying levels of Se.
Author

Year

Species

[Se] in diet,
ppm

GPx-3 activity,
EU/g proteina

Lei et al.

1995

Rat

0.002

2 ± 0.58

Lei et al.

1995

Rat

0.130

Weiss et al.

1996

Rat

0.007

Weiss et al.

1996

Rat

0.1

800.0

Lei et al.

1998

Pig

0.03

< 1.0

Lei et al.

1998

Pig

0.1

> 10.0

Lei et al.

1998

Pig

0.3

>15.0

2005

Chicken (Broiler)

0.067

2005

Chicken (Broiler)

0.3

Rowntree et al.

2004

Mulitparous cow

No supplemental

0.92

Rowntree et al.

2004

Multiparous cow

20 mg drench

1.34

Southern and
Payne
Southern and
Payne

a

95.33 ± 14.15
1.0

< 0.1×105 –
0.05×105
3×105 –
3.5×105

EU= Enzyme Unit; 1 EU is the amount GPx activity required to oxidize 1 µmol NADPH per
min.

shown that pigs fed a basal diet containing 0.03 ppm Se had an average GPx-3 activity of less
than 1.0 EU/g protein after 35 d on the diet (Lei et al., 1998). Pigs fed the basal diet
supplemented with either 0.1 ppm Se or 0.3 ppm Se as sodium selenite had an average GPx-3
activity of greater than10 EU/g protein and greater than15 EU/g protein, respectively, after 35
days on their respective diets (Lei et al., 1998, Table 2.7). Southern and Payne (2005) performed
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a study examining the effect of Se source in broilers. After being fed either a Se-deficient basal
corn-soybean meal diet containing 0.067 ppm Se with no supplemented Se or the basal diet
supplemented with 0.3 ppm Se as sodium selenite for 10 d, broilers had an average GPx-3
activity of less than 0.1 x 105 EU/g protein and between 3 and 3.5 x 105 EU/g protein,
respectively (Table 2.7). In addition, when the broilers initially fed the Se supplemented diet
were then fed the Se-deficient basal diet for an additional 12 d, GPx-3 activity fell to between 0.1
and 0.05 x 105 EU/g protein. GPx-3 activity of the broilers maintained on the Se-deficient basal
diet for the full 22 d period decreased only slightly further to 0.05 x 105 EU/g protein. In a study
conducted by Rowntree et al. in 2004 involving multiparous Hereford cows, plasma GPx-3
activities were reported to be 0.92 EU/g protein in unsupplemented cows versus 1.34 EU/g
protein in supplemented cows (Table 2.7).
Selenium Regulation of GPx
Selenium is found in the active site of all Se-dependent GPx enzymes, thus marking the
element as a significant regulator of Se-dependent enzyme activity, especially the activity of
GPx-1 (Sunde, 1997). The decrease in enzyme activity during Se-deficiency is due to a decrease
in the level of the GPx enzyme protein (Knight and Sunde 1987; Knight and Sunde, 1988). Most
studies examine the effect of Se-deficiency on GPx-1 activity, as it is the most dramatically
affected GPx enzyme (Weiss and Sunde, 1998). This is primarily because GPx-1 appears to
compete for Se less efficiently than other selenoproteins in nutritional Se-deficiency (Lei et al.,
1995). In addition to a loss in enzyme activity, a significant decrease in GPx mRNA is also
observed in Se-deficiency, resulting in a reduction of liver GPx-1 mRNA levels to less than 10%
of those levels observed in Se-adequate rats (Saedi et al., 1988; Yoshimura et al., 1988;
Christensen and Burgener, 1992; Hill et al., 1992). Although all of the Se-dependent GPx
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enzymes are regulated by the availability of Se, some are affected to a greater extent than others
(Moriarty et al., 1998).When comparing the Se regulation of GPx-1 mRNA to other
selenoprotein mRNAs, most researchers have found that GPx-1 mRNA levels decrease
considerably in Se-deficiency, whereas the levels for most other selenoproteins are affected less
dramatically (Hill et al., 1992; Lei et al., 1995; Weiss et al., 1997). In fact, GPx-4 mRNA levels
are not significantly reduced in Se-deficiency (Lei et al., 1995), although GPx-1 and 4 share
approximately 40% homology in their nucleotide sequences (Sunde et al., 1993). This downregulation has been further shown to be specific for GPx-1 mRNA using Se-repletion studies in
which rats were first maintained on a Se-deficient diet and were then fed a diet adequate in Se.
While internal control genes such as Poly-A polymerase mRNA, 18S rRNA, and β-actin mRNA
levels remained unaffected by Se-deficiency, GPx-1 mRNA levels dropped dramatically (Lei et
al., 1995; Bermano et al., 1996; Weiss et al., 1996; Weiss et al., 1997). When the rats were then
fed a diet adequate in Se, GPx-1 activity and mRNA levels increased rapidly. However, in spite
of the rapid decrease observed in GPx-1 activity and level during Se depletion followed by the
rapid increase observed in both during Se repletion, GPx-1 transcription levels are not affected
by deficiency (Toyoda et al., 1990; Christensen and Burgener, 1992). Furthermore, transcription
of the Se-dependent GPx genes by cultured cells are minimally effected by the availability of Se
in the culture medium (Chada et al., 1989) and the transport of GPx mRNA out of the nucleus of
the cell has also been shown to be unaffected by Se status (Sugimoto and Sunde, 1992). In
addition, studies utilizing isolated rat liver cells showed that Se-deficiency reduced the relative
abundance of cytoplasmic GPx-1 mRNA but did not have any effect on nuclear GPx-1 mRNA
(Moriarty et al., 1998). These results have led researchers to conclude that the regulation of GPx
by Se is via a posttranscriptional mechanism (Sunde, 1994) and that induced Se deficiency
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regulates the abundance of cytoplasmic GPx-1 mRNA, most likely by eliciting the decay of
cytoplasmic mRNA via nonsense-codon-mediated decay (Moriarty et al., 1998).
The SECIS Element and UGA-mediated Nonsense Decay
All eukaryotic selenoprotein mRNAs contain a cis-acting element in the 3’untranslated
region (UTR) that is required for the insertion of Se (Kinzy et al., 2005). This sequence is known
as the selenocysteine insertion sequence, or SECIS element, which consists of an RNA hairpin
loop composed of two helices separated by an internal loop (Walckzak et al., 1996; Martin et al.,
1998). This loop contains two highly conserved sequences: four non-Watson and Crick base
pairs consisting of UGAU and AAA in the stem and loop, respectively (Shen et al., 1993). The
four consecutive non-Watson and Crick base pairs located within the core of helix 2 are
responsible for conveying a structural/functional motif that is necessary for selenocysteine (Sec)
insertion during translation (Walczak et al., 1996; Walczak et al., 1998). In addition, a UGA
codon, which normally signals translational termination, is located within the open reading frame
and, in combination with the SECIS element located downstream within the 3’ UTR, codes for
the insertion of Sec, the 21st amino acid and the form in which Se is incorporated into
selenoproteins (Berry et al., 1991; Berry et al., 1993; Low and Berry, 1996). The recognition of
this codon as an insertion sequence for Sec requires the presence of Se and a metabolic pathway
that converts Se to selenocysteinyl-tRNA (tRNAsec) (Moriarty et al., 1998). Research has shown
that adding the GPx stem-loop structure to mRNA encoding a protein normally lacking a Se
moiety resulted in the inclusion of Sec in the protein and subsequent Se regulation. The
researchers interpreted this as an indication that the GPx 3’-UTR alone is adequate for signaling
the translation of a UTR as Sec (Shen et al., 1993). However, further work has shown that Sec
incorporation also requires three additional trans-acting elements, a Sec-specific translation-
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elongation factor (eEFSec), SECIS binding protein 2 (SBP2), and ribosomal protein L30 (rpL30)
(Kinzy et al., 2005).
In addition to contributing to the incorporation of Se into selenoproteins, the combined
function of the UGA codon and the SECIS element are considered to be responsible for
mediating the nonsense decay of cytoplasmic GPx mRNA in the absence of adequate Se
(Moriarty, 1998). The modification of cytosolic mRNA turnover by a nutrient for the regulation
of eukaryotic gene expression is not an unusual concept. In numerous cases, the availability of
nutrients serves to alter gene expression for products that are relevant to their metabolism
(Christensen and Burgener, 1992). Iron availability, for example, can alter the expression of
transferrin by the binding of iron to the cytosolic transferrin mRNA receptor, which in turn
stabilizes the mRNA, protecting it from degradation (Klausner and Harford, 1989; Müllner et al.,
1989). In addition, there are numerous organisms including various species of bacteria, yeasts,
and vertebrates that have mechanisms for the elimination of mRNAs that have prematurely
terminated because of frameshift or nonsense mutations (Peltz et al., 1994; Maquat, 1995; RuizEchevarria, 1996). Interestingly, the majority of mammalian cells that have been studied have
mRNAs that are degraded while associated with the nucleus (Maquat, 2005); however,
selenoprotein mRNAs decay after transport into the cytoplasm, underlined by the fact that Sedeficiency results in a decrease in cytoplasmic GPx-1 mRNA but not in a decrease in nuclear
GPx-1 pre-mRNA or mRNA (Moriarty, 1998). The combined work of Weiss and Sunde (1997)
and Moriarty (1998) suggest that the combination of the UGA codon and the SECIS element are
required for the decrease in GPx-1 mRNA abundance as a result of Se-depletion. Kinzy et al.
(2005) reinforced this model of UGA codon nonsense-mediated decay while characterizing the
SBP2 complex. According to his group, during translation, when the ribosome pauses at the
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UGA codon, the SECIS element is recognized by SPB2, which is bound to the ribosome. As
SBP2 binds to the SECIS element, it briefly releases the ribosome, allowing access to the
ribosomal A-site and incorporation of the tRNAsec via the eEFSec/tRNAsec complex. In the
absence of Se, there is no t-RNAsec to add Sec to the growing protein and translation is thus
terminated. It is currently unknown whether the nonsense-mediated decay of the mRNA that
follows occurs while the truncated protein and mRNA are still associated with the ribosome or if
it occurs within “cytoplasmic foci”, ribosome-free sites of general mRNA decay (Maquat, 2005).
Incorporation of Se into GPx and Other Selenoproteins
Selenocysteine is located 41 residues from the N-terminal end of rat liver GPx (Condell
and Tappel, 1982), 45 residues from the end of bovine GPx (Gunzler et al., 1984), and 47
residues from the end of murine GPx (Chambers et al., 1986). In 1987 Sunde and Evenson
elucidated the origin of the Sec residue by perfusing isolated rat liver with amino acids labeled
with either C14 or H3. They determined that the skeletal precursor to Sec was not cysteine, as
previously thought, but serine (Ser).
The formation of Sec outlined by Burk (1991) is based primarily on the mechanism as is
understood in E. coli and requires both a Ser-charged tRNA and a source of selenide. However,
there are indications that a similar scheme exists in mammals (Burk, 1991; Hubert et al., 1996;
Kinzy et al., 2005) This mechanism requires a unique tRNA (tRNA[ser]sec) that is first charged
with a Ser residue by the catalytic enzyme seryl-tRNA synthetase, as Sec synthesis occurs on its
tRNA (Driscoll and Copeland, 2003). The Ser must then be activated to phosphoseryltRNA[ser]sec before it can be replaced by Se. It is thought that this step is carried out by a kinase in
animals, but the specific mechanism is not currently known (Lee et al., 1989). The conversion of
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phosphoseryl-tRNA[ser]sec to tRNAsec with selenophosphate as the Se donor is then catalyzed by
selenocysteine synthase (Hubert et al., 1996) (Figure2.2).
Step 1 tRNA[ser]sec + serine ----seryl-tRNA ligase-----Æ seryl-tRNA[ser]sec
Step 2 seryl-tRNA[ser]sec -----kinase?-------Æ phosphoseryl-tRNA[ser]sec
Step 3

phosphoseryl-tRNA[ser]sec + selenophosphate ---selenocysteine synthase---Æ tRNAsec

Figure 2.2. Eukaryotic selenocysteine synthesis, from Burk (1991), with changes.
The addition of Sec to selenoproteins, including GPx, is a co-translational event in which
the UGA codon codes for the addition of Sec via tRNAsec. As previously outlined, during
translation of the selenoprotein mRNA, SBP2 is bound to the translating ribosome. The
elongation factor eEFsec serves to escort tRNAsec to the ribosomal A-site (Fletcher et al., 2001).
When the ribosome arrives at the UGA codon, it pauses, allowing SBP2 to recognize both
specific nucleotides within the SECIS element and the eEFSec/tRNAsec complex. SECIS binding
protein 2 then binds both the SECIS element and eEFSec and is temporarily released from the
ribosome, allowing the eEFSec/tRNAsec complex access to the UGA codon within the ribosomal
A-site and subsequent incorporation of Sec instead of translation termination. The addition of
Sec also results in an alteration of the SECIS element conformation. Once the tRNA has
dissociated from the ribosome, the third protein necessary for the completion of Sec
incorporation, rpL30, binds to the now altered SECIS element, releasing SBP2 and allowing its
re-association with the ribosome (Kinzy et al., 2005).
Quantification of the GPx Enzyme mRNAs
In addition to tissue Se concentrations and activity of various GPx enzyme tissue
activities, comparison of relative GPx mRNA levels is often a desirable method of determining
Se status. However, as previously mentioned, not all selenoprotein mRNA levels are affected
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similarly by Se depletion (Moriarty et al., 1998) and there appears to be some process of
prioritization concerning selenoprotein expression in Se-deficiency. Some selenoprotein
mRNAs, such as GPx-4 mRNA, are affected very little by a decrease in Se availability, whereas
others, such as GPx-1 mRNA, are affected fairly dramatically. Despite all that is currently
known about selenoproteins and their regulation, the specific mechanisms by which this
regulatory process occurs are complex and currently poorly understood (Bruzelius et al., 2007).
The utilization of polymerase chain reaction (PCR) in mRNA quantification is considered
appropriate due to its high sensitivity, especially in detecting relatively small quantities of
product (Moriarty et al., 1998). High detection sensitivity and accuracy are both desirable
characteristics when determining relative quantities of mRNA, especially when n-fold
differences between samples may be as small as 2; Real-time PCR (Q-PCR) has been shown to
consistently provide both of these qualities (Cheng and Maquat, 1993; Moriarty et al., 1998).
Because of its extreme sensitivity to Se status, GPx-1 mRNA is considered an acceptable
candidate for comparison of mRNA levels as an indicator of Se status. Research has shown that
GPx-1 mRNA levels reliably decrease during Se-deficiency (Christensen and Burgener, 1992;
Weiss et al., 1996; Lei et al., 1998; Moriarty, 1998). Glutathione peroxidase-1 mRNA levels
have also been used as a parameter contributing to the determination of dietary Se requirement
within a specific species and sex during specific developmental stages (Weiss et al., 1996). In
fact, comparison of male rat liver GPx-1 mRNA to that of female rats showed that female rats
had mRNA levels that were 0.7 fold higher, when both sexes were maintained on a diet
containing 0.1 ppm Se as sodium selenite (Weiss et al., 1996). Christensen and Burgener (1992)
report a 93-95% reduction in GPx-1 mRNA hybridization in rats fed a Se-deficient diet
containing 0.02 ppm Se versus rats fed a diet supplemented with 0.5 ppm Se as sodium selenite.
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Weiss et al. (1996) showed that female rats fed a Se-deficient basal diet containing 0.007 ppm Se
had liver GPx-1 mRNA levels that were 11 ± 1 % of that observed in female rats fed the basal
diet supplemented with 0.1 ppm Se as sodium selenite. Other researchers using rats or mice
maintained on a Se-deficient diet for a period of time ranging from 42-135 d have reported
decreases in liver GPx-1 mRNA levels in animals of as much as 80-90% (Saedi et al., 1988;
Toyoda et al., 1990; Lei et al., 1995). Relative mRNA levels have also been used as an indicator
of Se status in some livestock species, but its use is thus far rare. In fact, the only livestock
species in which the effect of Se-deficiency on relative mRNA GPx-1 levels has been determined
is the pig. Lei et al. (1998) reported a 50% relative decrease in liver GPx-1 mRNA levels for pigs
maintained for 5 wks on a Se-deficient diet containing 0.03 ppm Se versus pigs maintained for
the same time period on a diet supplemented with 0.2 ppm Se. In contrast, Hostetler et al. (2006)
reported finding no significant difference in sow liver GPx-1 mRNA level when sows were fed
diets consisting of barley and peas grown in Se-deficient soils and either supplemented or
unsupplemented with Se as sodium selenite. Their diets were analyzed as containing 0.05 ppm
Se in the Se-deficient diet and 0.39 ppm Se in the Se adequate diet. However, the researchers
concluded that, based on the GPx activities and mRNA levels that they observed in the livers of
the sows, the sows were actually not Se-deficient, but instead were of marginal Se status. Taken
with the work of Lei et al. (1998), this suggests that the margin of Se required to obtain Sedeficient status based on GPx-1 mRNA level may be relatively small in domestic livestock
species, requiring extremely low levels of Se to achieve Se-deficiency sufficient to significantly
decrease levels of liver GPx-1 mRNA.
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Selenium and Immunity
There is ever-increasing evidence suggesting the close relationship of nutritional status to
immunity in livestock animals and even humans (Failla, 2003; Chirase, et al.,1991). It has been
widely shown that nutrient-deficient hosts often develop more severe pathology than their
nutritionally-adequate counterparts when challenged with a viral infection. Antioxidants have
long been considered important in immune function and have recently been studied closely to
determine their particular role in combating host oxidative stress (Beck, 1999). In particular, the
trace mineral Se and the fat-soluble vitamin E have been of considerable interest, as it has been
shown that Se deficiencies often result in numerous disease states that are often associated with a
concurrent deficit in vitamin E (Turner and Finch, 1991; Wichtel, 1998; Beck and Levander,
2000). Other trace minerals have also been considered to have some antioxidant or immune
function, including Fe, Zn, and Cu, and data tend to support the conclusion that inadequate
supply of such essential micronutrients is closely related to a decrease in the activities of cells
intimately involved in the immune response (Failla, 2003; Hatfield, 2002). A deficiency in Se
has been shown to have adverse effects on host immunity and host ability to adequately respond
to and clear virus following an infection (Beck, 1999). This decrease in immune effectiveness as
a result of selenium deficiency may be due to a decrease in host immune cellular function or
even changes in the virus itself brought about by exposure to increased levels of ROS (Beck,
1999).
In addition to direct effects of Se-deficiency on the immune system, anti-oxidation
suppression has been shown to influence viral agents. A number of studies have convincingly
demonstrated that a non-virulent strain of the Picornavirus Coxsackievirus B3 will become a
virulent strain of the virus in Se-deficient mice. When infected with a non-virulent strain of
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Coxsackievirus B3, Se-deficient mice develop cardiomyopathy. (Beck, 1994a; Beck 1994b;
Beck 1994c; Beck 1995; Beck 1998). Furthermore, when virus isolated from the Se-deficient
mice was used to infect Se-adequate mice, the Se-adequate mice then too developed severe
cardiomyopathy. These results demonstrated that replication of a normally benign virus in a Sedeficient host could result in a virus with an altered genotype, such that increased pathogenicity
occurred (Beck, 1999). The same result has been achieved by infecting Se-deficient mice with
influenza virus (Beck, 2001). Interestingly, it was shown that the Se-deficiency had no effect on
antibody response (Beck, 2001), suggesting that antibody titers alone may not be an adequate
means for determining virulence or host ability to fight infection. Thus, Se-deficiency may prove
to be a double-edged sword and further research into this area must be conducted to determine
the extent to which Se-deficiency contributes to infectious disease.
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CHAPTER III
THE INFLUENCE OF SE DEFICIENCY IN HOLSTEIN DAIRY CALVES ON TISSUE
SE CONCENTRATION, GPX-1 AND 3 ACTIVITY, AND RELATIVE LEVELS OF
LIVER GPX-1 MRNA
Introduction
There has been considerable research concerning the effect of induced Se-deficiency on
tissue Se concentration and GPx-1 and 3 activity in cattle of all sexes and ages. However, to our
knowledge there is no data currently available concerning the effect of Se status on relative liver
GPx-1 mRNA levels in growing calves. Given the considerable differences in results observed
by various laboratories in a wide variety of species, we believe that it is not only necessary but
also prudent to both establish ranges of GPx-1 and 3 activities for our laboratory and study the
effect of Se-status on liver GPx-1 mRNA in growing calves. We hope to then use this data to
further research the effects of Se-deficiency on oxidative stress in growing calves.
Materials and Methods
Experimental Design
The LSU Agricultural Center Animal Care and Use Committee approved all animal
procedures. Male Holstein calves (n=17), with a mean body weight of 42.96 kg, were purchased
within one week after birth from the Southeast Research Station, Franklinton, LA. All calves
were born between September, 2006 and December, 2006. Calves were housed individually at
the Louisiana State University Agricultural Center Central Station, Baton Rouge, LA, in pens
equipped with stainless steel bowl-waterers. Upon arrival, calves were administered 6 cc of
Florfenicol subcutaneously and their navels dipped in 7% iodine solution. Each calf was then
assigned an individual pen. Calves were fed a commercially available milk replacer (NutraBlend,
Neosho, MO) containing 20% protein and 20% fat at 10% of birth weight twice daily until 21 d
of age, at which time they were randomly assigned to either a Se-deficient (n=7) or Se-adequate
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(n=7) starter diet. In addition, at this time 3 calves were euthanized for collection of baseline
liver samples. Diet assignment was determined by pen location; pens were arranged so that Seadequate and Se-deficient animals were housed adjacent to one another in alternating fashion,
both lengthwise down the barn and across the center isle dividing the barn. This arrangement was
implemented in order to account for possible confounding variation in barn temperature,
humidity, and availability of sunlight. Until 28 d of age, calves received 50% of their diet as
commercial milk replacer and the rest as their respective starter diet. Beginning at 28 d of age
calves were completely weaned to the starter phase of one of two diets:
1) Torula yeast basal diet containing no added Se (n = 7)
2) Torula yeast basal diet containing 0.1 ppm Se as sodium selenite (n = 7)
Diets were fed in three phases (Reffett et al., 1988) (Table 3.1) and all calves remained on the
initially-assigned Se-deficient or Se-adequate diet until trial completion. Calves were fed and
disappearance measured and recorded twice daily.
To ensure that exposure to exogenous sources of Se were minimal, water samples were
collected from each of the automatic waterers and analyzed for Se concentration. The analyzed
Se content of the water samples was less than 0.005 ppm Se. Analysis of calf diets showed that
the Se adequate diet in phase 1 contained 0.158 ± 0.034 ppm Se, while the Se-deficient diet
contained 0.025 ± 0.008 ppm Se.
Selenium status of calves was determined by cytosolic GPx-1 and plasma GPx-3 activity.
Jugular blood was collected every 28 d beginning at 28 d of age until trial completion. Calves
were weighed upon arrival at the Central Research Station barn. Calves were then weighed on 14
d of age and again every 14 d thereafter. Trial termination for each calf occurred upon reaching
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180 d of age. In addition, 2 calves in the Se adequate treatment group died of bloat between 140
and 168 d of age.
As previously stated, three calves were euthanized via intravenous Phenobarbital
injection at 21 d of age and liver tissue was collected and snap-frozen in liquid nitrogen and
stored at -80º C in order to obtain a baseline (BSL) measurement for the group. Calves from each
treatment (n=4) were then euthanized at 180 d of age for liver tissue collection and analysis.
Liver tissue was wrapped in labeled aluminum foil and snap frozen in liquid nitrogen for storage
at -80ºC. Messenger RNA was then isolated from each tissue sample for Q-PCR analysis and
comparison.
Table 3.1. Composition of Torula yeast based diet fed to calves, from Reffett et al., 1988.
%
Ingredient

Starter Diet (56d)

Phase 2 (84d)

Phase 3 (12d)

Torula Yeasta

30.0

25.0

20.0

Cottonseed Hulls

20.0

30.0

30.0

Dextroseb

10.0

4.0

---

Cornstarchb

35.0

35.0

44.3

Corn Oilb

3.0

3.0

3.0

Mineral/Vitamin
Mixc,d

2.0

2.0

1.7

Urea

---

1.0

1.0

a

Provesta Flavor Ingredients, Hutchinson, MN.
International Ingredients Corporation, St. Louis, MO.
c
Contained the following in mg/kg diet: Ca, 150,000; P, 60,000; Na, 85,000; Mg, 25,000; K,
10,000; Co, 20; Cu, 2500; I, 200; Mn, 4,000; Zn, 6,000.
d
Contained the following per kg of diet: retinyl acetate, 136,079 IU; cholecalciferol, 13,608 IU;
α-tocopherol acetate, 136 IU.
b
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Measurement of Diet Se Concentration
Diets were analyzed for Se concentration by neutron activation at the University of
Missouri-Columbia Research Reactor Center. Nine replicates were performed in the analysis of
each sample so that the mean obtained from analysis did accurately reflect the Se concentration.
Collection and Processing of Blood
Blood was collected from each calf every 28 d beginning at 28 d of age. Approximately
10 mL of blood were collected in 10 mL heparinized Vacutainer tubes (BD Vacutainer Systems,
Franklin Lakes, NJ) via jugular venipuncture. Each blood sample was then centrifuged at 2,000 x
g and 4° C for 10 min. Plasma was removed from each sample and placed into a labeled 5 mL
Falcon® tube (BD Biosciences, San Jose, CA) and stored at -80° C. The remaining packed
erythrocytes were then washed in ice cold phosphate buffered saline and centrifuged 10 min at
2,000 x g at 4° C for a total of three washes. Packed erythrocytes were then pipetted into
individually labeled 1.5 mL microcentrifuge tubes and stored at -80° C.
Measurement of Plasma GPx-3 Activity
Because of the relatively quick turnover of plasma proteins and other cells, plasma GPx-3
activity is an indicator of short-term Se status, providing a relatively quick picture of an animal’s
immediate selenium condition (Gerloff, 1992). Plasma GPx-3 activity was determined using
Glutathione Peroxidase Activity Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI)
and the ELx808 Absorbance Microplate Reader (BioTek Instruments, Inc., Winooski, VT). The
Gen 5 data analysis software (BioTek Instruments, Inc., Winooski, VT) was used for data
reduction and absorption analyses. Briefly, 100 µL of Assay Buffer (50 mM Tris-HCl, pH 7.6,
containing 5 mM EDTA), 50 µL of Co-Substrate Mixture (a lyophilized powder consisting of
NADPH, glutathione, and glutathione reductase), and 20 µL of sample plasma were pipetted, in
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triplicate per sample, into a 96 well plate, for a total volume per well of 170 µL. Three controls
were also utilized: a blank, consisting of glass-filtered water, a negative enzyme control into
which no glutathione peroxidase was added, and a positive control containing 20 µL of supplied
purified bovine glutathione peroxidase. Each control was performed in triplicate within each
plate that was analyzed in order to account for differences between plates. Each plate was
incubated at 25° C and absorbance at 340 nm measured by the plate reader at time zero and then
at one min intervals for 6 min, for a total of seven absorbance readings. GPx activity was
calculated for each individual well by first determining the change in absorbance at 340 nm
(Abs340) per min. Briefly, for each individual well, two points were selected on the linear portion
of the resulting curve and the change in absorbance over that time period was calculated using
the following equation:
∆A340/min = (∆A340 @ Time 2 - ∆A340 @ Time 1) / Time 2 (min) – Time 1 (min),
where ∆A340 was the absorbance at each respective time and Time 1 was the first chronological
time in min and Time 2 was the second chronological time in min. The ∆A340/min was then also
calculated for the non-enzymatic control wells and this rate subtracted from that of the sample
wells. Activity was then determined using the NADPH extinction coefficient of 0.00373 µM-1,
which is the value adjusted for the 0.6 cm path length of the solution in the well from the actual
value of 0.00622 µM-1. Activity was calculated using the following formula:
GPx activity = ( |∆A340/min| / 0.00373 µM-1) × (0.19 ml / 0.02 ml) = nmol/min/mL,
where |∆A340/min| was the absolute value of the calculated absorbance at 340 nm per min and
one enzyme unit was defined as the amount of enzyme that will cause the oxidation of 1 nmol
NADPH per min.
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Glutathione Peroxidase-3 activity was expressed as EU per gram protein, where 1 EU
was equivalent to the amount of GPx activity required to oxidize 1 µmol of NADPH per 1 min.
Plasma protein concentrations were determined using the Quick Start Bradford Protein Assay Kit
1 (Bio-Rad Laboratories, Inc,. Hercules, CA), an assay first described by Bradford (1976) in
which the dye agent, Coomassie Brilliant Blue G-250 is used to bind solubilized protein. Plasma
samples were diluted 1:50 in water before assaying. Briefly, a standard curve was constructed
using 2 mg/mL bovine serum albumin (BSA) in which seven concentrations ranging from 0
µg/mL BSA to 2000 µg/mL BSA were used. Standards were analyzed in triplicate. Samples
were then diluted 1:50 using glass-filtered H2O and 20 µL were pipetted into each of two
disposable cuvettes (Bio-Rad Laboratories, Inc,. Hercules, CA). To initiate the reaction, 1 mL of
Coomassie Brilliant Blue (Bio-Rad Laboratories, Inc,. Hercules, CA) was added to each cuvette
and allowed to incubate for 5 min after gentle inversion. Absorbance was measured at 595 nm
using the Smart Spec Plus Spectrophotometer (Bio-Rad Laboratories, Inc., Hercules, CA) and
concentrations were calculated using the previously constructed standard curve. Thus, using
protein concentrations, all GPx activities were expressed per g protein.
Measurement of Cytosolic GPx-1 Activity in Erythrocytes
Due to the slow turnover of erythrocytes, with which 98% of GPx activity is associated
(Scholtz and Hutchinson, 1979), and the fact that GPx-1 is incorporated into erythrocytes during
erythropoiesis, GPx-1 activity in erythrocytes is considered an indicator of long-term Se status
(Gerloff, 1992). Cytosolic GPx-1 activity was determined using Glutathione Peroxidase Activity
Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI) and the ELx808 Absorbance
Microplate Reader (BioTek Instruments, Inc., Winooski, VT), as previously described. Thawed
erythrocytes were then lysed in ice-cold glass-filtered water to a 1:4 dilution, followed by 1:100
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dilution of the lysate in sample buffer (50 mM Tris-HCl, pH 7.6, containing 5 mM EDTA and 1
mg/mL BSA). The assay procedure and activity calculations were the same as previously
described for determination of Plasma GPx-3 activity.
Erythrocyte GPx-1 activities were expressed as enzyme units per gram of hemoglobin,
where 1 EU was equivalent to the amount of GPx activity required to oxidize 1 µmol of NADPH
per 1 min. Hemoglobin was measured using QuantichromTM Hemoglobin Assay Kits (BioAssay
Systems, Hayward, CA). Briefly, blank and standard wells were made in triplicate for each plate
performed by pipetting 50 µL of water for the standards and 50 µL of provided standard solution
containing 100 mg/dL hemoglobin in 0.02% tartrazine, followed by the addition of 200 µL water
into each of three wells. Blood samples were first diluted 100 fold in ice-cold distilled water.
Samples were analyzed in duplicate by pipetting 50 µL of sample into each of two wells,
followed by 200 µL of Reagent (0.40% sodium hydroxide and 2.60% Triton X-100), provided in
the kit. Plates were then incubated for 5 min at approximately 27º C. Absorbance at 400 nm was
then read using a Power Wave Microplate Spectrophotometer (BioTek Instruments, Inc.,
Winooski, VT). Absorbance data were collected by the Gen5 Software System (BioTek
Instruments, Inc., Winooski, VT). Hemoglobin concentration (mg/dL) was calculated with the
following equation:
(Abs400 sample – Abs400 blank / Abs400 standard – Abs400 blank) * 100 * n,
where “n” was the dilution factor.
Measurement of Cytosolic GPx-1 Activity in Liver Tissue
Cytosolic GPx-1 in liver tissue was again determined using Glutathione Peroxidase
Activity Assay Kits (Cayman Chemical Corporation, Ann Arbor, MI) and the ELx808
Absorbance Microplate Reader (BioTek Instruments, Inc., Winooski, VT). Liver tissue collected
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from three BSL calves, four Se adequate calves, and four Se-deficient calves and snap-frozen in
liquid nitrogen was used to determine GPx-1 activity. Briefly, approximately 1g of each liver
sample was individually ground under liquid nitrogen with a frozen mortar and pestle without
allowing the samples to thaw. The finely ground sample was then placed into a 14 mL Falcon®
tube (BD Biosciences, San Jose, CA) and 10 mL of cold buffer (50 nM Tris-HCl (pH 7.5), 5 mM
EDTA, and 1 mM DTT) were added to the sample and mixed thoroughly. The samples were then
each centrifuged at 10,000 x g for 15 min at 4° C and the supernatant removed and stored at -80°
C for no longer than one month. Hemolysate dilutions of 1:400 were prepared using sample
buffer (50 mM Tris-HCl, pH 7.6, containing 5 mM EDTA and 1 mg/mL BSA). The liver
hemolysate was then used to determine liver GPx-1 activity using the Cayman Chemical
Glutathione Peroxidase Activity kit (Cayman Chemical Corporation, Ann Arbor, MI), but with
some minor modifications. Briefly, 70 µL of Assay Buffer (50 mM Tris-HCl, pH 7.6, containing
5 mM EDTA), 50 µL of Co-Substrate Mixture (a lyophilized powder consisting of NADPH,
glutathione, and glutathione reductase), 20 µL Double Strength Drabkin’s Reagent (Potassium
cyanide/Potassium ferricyanide), 10 µL 0.01 M NaN3, and 20 µL of sample hemolysate were
pipetted, in triplicate per sample, into a 96 well plate placed on ice, for a total per well volume of
170 µL. Four controls were also utilized: a blank, consisting of glass-filtered water, a blank
consisting only of reagent and to which no hydrogen peroxide was added, a negative enzyme
control into which no glutathione peroxidase was added, and a positive control containing 20 µL
of supplied purified bovine glutathione peroxidase. Each control was performed in triplicate
within each plate that was analyzed in order to account for differences between plates. To initiate
the reaction, 20 µL of 12 mM H2O2 was pipetted into each well used and then the plate was
incubated at 25° C and absorbance at 340 nm measured by the plate reader at time zero and then
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at one min intervals for 10 min, for a total of eleven absorbance readings. Liver GPx-1 activities
were then calculated as outlined for GPx-3. GPx-1 activity in liver tissue was expressed as
enzyme units per gram protein, and tissue protein concentrations were determined on 1:10
dilutions of liver tissue hemolysate in water using the Quick Start Bradford Protein Assay Kit 1
(Bio-Rad Laboratories, Inc., Hercules, CA) as previously described.
Measurement of Liver Tissue Se Concentration
Liver tissue Se concentration was determined via the method of Martin and Williams
(1989), with some changes. Briefly, liver samples were dried at 60º C in a drying oven and
weighed every 12 h for 36 h until completely dry. Approximately 0.5 g of tissue from each
sample was weighed in duplicate into Teflon® microwave tubes and 4 mL of 70% HNO3 were
added to each tube. Samples were allowed to pre-digest for 12 h before digestion. Liver samples
were then digested in a MARS5 microwave digester (CEM Corporation, Matthews, NC) at 1,200
watts on maximum power with a 15 min ramp time followed by 15 min of digestion at 200º C.
After cooling, digested samples were brought to 10 mL total volume with deionized,
distilled water and stored in 14 mL polystyrene Falcon® tubes (BD Biosciences, San Jose, CA)
until processing. Selenium concentration was determined by the method of GFAAS using a
Perkin Elmer Zeeman 5100 Graphite Furnace Spectrophotometer (Perkin Elmer Life and
Analytical Sciences, Inc., Waltham, MA) at 196 nm.
Isolation of mRNA from Liver Tissue
Total mRNA was isolated from frozen liver tissue using the Dynabeads® mRNA
DIRECT Isolation Kit (Dynal Biotech, Inc., Lake Success, NY, USA). Approximately 30 to 50
mg of frozen liver tissue stored at -80º C was ground in liquid nitrogen using an autoclaved
mortar and pestle frozen in liquid nitrogen. The tissue was not allowed to thaw at any time before
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the addition of 1,250 µL of lysis/binding buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10
mm EDTA, 1% lithium dodecylsulfate, and 5 mM dithiothreitol) to the sample. The sample was
then homogenized for 3 to 5 min in the lysis/binding buffer using a pair of autoclaved hemostatic
forceps previously wiped with RNase Away (Molecular Bio-Products, Inc., San Diego, CA). The
lysed sample was then forcibly passed 3 to 5 times through a 21 gauge needle using a 3 cc sterile
syringe in order to shear the DNA. After centrifuging the sample for 60 s, the supernatant was
removed and added to 250 µL of pre-washed Dynabeads Oligo (dT)25. The sample and beads
were allowed to hybridize for 5 min with continuous mixing in a roller mixer in order to give the
mRNA poly-A tail time to anneal to the Dynabead (dT)25. The microcentrifuge tube containing
the mixture was then placed onto the Dynal MPC-E-1 magnetic separator for 2 min and the
resulting supernatant discarded. The remaining beads-mRNA complex was then washed twice in
1 mL of washing buffer A (10 mM Tris-HCl, pH 8.0, 150 mM LiCl, 1 mM EDTA, and 0.1%
lithium dodecylsulfate) followed by a single wash in 1 mL of washing buffer B (10 mM TrisHCl, pH 8.0, 150 mM LiCl, and 1 mM EDTA). The beads-mRNA complex was then washed in a
additional 40 µL of washing buffer B. After discarding washing buffer B, the mRNA was eluted
by adding 25 µL of 10 mM Tris-HCl to the beads-mRNA complex and incubation for 2 min in a
75º C water bath. The microcentrifuge tube containing the eluted RNA and beads was then
placed immediately onto the magnet and the free mRNA was removed and added to a labeled
nuclease-free 0.5 mL centrifuge tube. The mRNA was then kept on ice for immediate cDNA
synthesis.
Reverse Transcriptase cDNA Synthesis
Complementary DNA (cDNA) was synthesized using the iScript cDNA Synthesis Kit
(Bio-Rad Laboratories, Inc., Hercules, CA). Briefly, 12.5 µL of isolated template mRNA was
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added to 4 µL of 5x iScript reaction mix, 2.5 µL nuclease-free water, and 1 µL reverse
transcriptase in a PCR tube for a total volume of 20 µL. A no reverse transcriptase control
reaction containing 12.5 µL isolated template mRNA, 4 µL 5x iScript reaction mix, 2.4 µL
nuclease-free water and 1 µL autoclaved water was also performed. Reverse transcriptase PCR
(RT-PCR) was performed using an iCycler ThermalCycler (Bio-Rad Laboratories, Inc.,
Hercules, CA) at 25º C for 5 min, 42º C for 30 min, and a 5 min denaturing step at 85º C with a
final hold temperature of 4º C.
Primer Design for PCR Amplification
Primers for PCR amplification of GPx-1 cDNA were designed based on a published
bovine nucleotide sequence (Mullenbach et al., 1988; GenBank Accession No. X13684, 828
nucleotides) using the Beacon Designer 4.0 software program (PREMIER Biosoft International).
Primers for PCR amplification of Poly-A polymerase cDNA were based on a published bovine
nucleotide sequence (Raabe et al., 1991; GenBank Accession No.X63436, 3431 nucleotides).
Primers were synthesized by Life Technologies (Invitrogen, Carlsbad, CA) (Table 3.2).
Table 3.2. Primers for amplification of GPx-1 and Poly-A cDNA.
Accession
Number

Gene
Poly-A

X63436

GPx-1

X13684

Primer Sequence
Sense AAGCAACTCCATCAACTACTG
Antisense ACGGACTGGTCTTCATAGC
Sense AACGCCAAGAACGAGGAG
Antisense GGACCAGGTGATGAACTTAGG

Amplicon
Length (bp)
169
204

Validation of Primers and RNA Isolation
Based on previous work (Wrenzycki, 1998), Poly-A polymerase (Poly-A) was chosen as
an internal control gene for this experiment, as its expression and abundance are unaffected by
Se status (Lei et al., 1995). The primers for this gene and GPx were validated by performing a
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PCR amplification using cDNA from the calibrator, which was cDNA combined from the liver
tissue samples taken from the three BSL calves slaughtered at 21 d of age. Each reaction
contained 5µL of 10x PCR buffer, 1 µL dNTP (10 µL dGTP, 10 µL dCTP, 10 µL dATP, 10 µL
dTTP, and 60 µL autoclaved water), 1µL forward primer (either GPx or Poly-A), 1µL reverse
primer (either GPx or Poly-A), 39µL autoclaved water, 1µL template cDNA, and 2 µL
Jumpstart™ REDTaq™ DNA Polymerase (Sigma, Saint Louis, MO) for a total reaction volume
of 50µL. A working master mix for each primer set was first made, consisting of all reaction
components with the exception of the template cDNA. This mix was then pipetted into
individual PCR tubes and 1µL cDNA added to each PCR tube for a total reaction volume of 50
µL. Amplification was performed in the iCycler Thermalcycler (Bio-Rad Laboratories, Inc.,
Hercules, CA) with a 95° C initial denaturing step for 1 min, 35 cycles of 30 s denaturation at
95° C, 30 s annealing at 56° C, and 30 s extension at 72° C, followed by a 4 m final extension at
72° C and a final hold temperature of 4° C. Gel electrophoresis was then performed by loading
25 µL of each sample into individual wells of a 2% agarose gel. A 100 bp ladder added to the
same gel was used to confirm the size of the resulting amplicon for each gene of interest. The
presence of GPx mRNA in all isolated samples was then confirmed using the same protocol as
discussed previously (Figure 3.1).
Optimization and Validation of Quantitative Real Time PCR (Q-PCR)
Optimization of primer conditions is a necessary part of ensuring that primers amplify
only target cDNA during PCR. Primer annealing temperature was optimized by utilizing an
annealing temperature gradient consisting of five temperatures from 50° C to 65° C. Gel
electrophoresis in a 2% agarose gel was then used to determine the best annealing temperature
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based on amplicon signal intensity. An annealing temperature of 56° C was chosen based on the
apparent

quantity

Figure 3.1. Gel of bovine GPx cDNA in samples and individual baseline calves. The no reverse
transcriptase controls are located in the lane to the right of each sample. The 100 bp ladder is in
the first well, to the left of samples in all three gels.

47

Figure 3.2. Gel of annealing temperature gradient. The amplicon obtained by annealing at 56º C
is the fourth well from the bottom of the gel. The first well is a 100 bp ladder.
of amplicon as determined by relative band brightness when electrophoresed and placed into a
Gel Dock Eq (Bio-Rad Laboratories, Inc., Hercules, CA) for viewing under ultraviolet light
(Figure 3.2).
In order to ensure that the chosen primers were indeed quantitative in amplification, tenfold dilution series were performed with the calibrator, an equal mix of cDNA from the three
BSL calves. Both Poly-A and GPx-1 primers were validated in this manner in separate reactions.
Ten-fold dilutions were prepared by first adding 2 µL of undiluted calibrator cDNA to 18 µL of
autoclaved water, making a 1:10 dilution. From this dilution, 1:100, 1:1000, and 1:10,000
dilutions were made. In addition, a “no template control” consisting of only autoclaved water and
lacking any template cDNA was also made and utilized to ensure that there was no
DNAcontamination of the reaction. Each reaction consisted of 12.5 µL of SYBR Green (Bio-Rad
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Laboratories, Inc., Hercules, CA), 1 µL of sense primer for the gene to be amplified, 1 µL of
anti-sense primer for the gene to be amplified, 9.5 µL of autoclaved water, and 1µL of cDNA
from one of the dilutions for a total reaction volume of 25 µL. A master mix containing all
reactants with exception of template cDNA and dilutions was first made and 96 µL of said
master mix was pipetted into six 0.5 µL microcentrifuge tubes. Into each tube was then pipetted
4 µL of one of the dilutions. The no template control reaction tube received 4 µL of autoclaved
water. The contents of each tube were then pipetted in triplicate into half of a 96-well plate, for a
total volume of 25 µL per well. The plate was then placed into an iCycler thermal cycler (BioRad Laboratories, Inc., Hercules, CA) and a two-step amplification was performed with an initial
denaturation step for 3 min at 95° C for 1 cycle, followed by 40 cycles of a two step process
consisting of denaturation for 10 s at 95° C and annealing for 45 s at 56° C. Florescence was
measured during this time and real-time analysis performed using the My iQ software system
(Bio-Rad Laboratories, Inc., Hercules, CA). This was followed by 1 cycle of denaturation at 95°
C for 1 min, one cycle of annealing at 56° C for 1 min, and 80 cycles at 55° C. After cycle 2 at
55° C, the temperature was increased by 0.5° C intervals and melt curve data collected for the
duration of the cycles. A final hold temperature of 10° C was then maintained. From each
analysis a standard curve, melt curve, and dilution Ct values of the ten-fold dilutions were
created and the efficiency and correlation coefficient provided by the My iQ Reverse
Transcription PCR Detection software system (Bio-Rad Laboratories, Inc., Hercules, CA)
(Figure 3.3). All of the target genes in both the samples and calibrator had efficiencies between
80 and 120%, which is the range considered acceptable for quantitative PCR. Correlation
coefficients for all target genes were also acceptable, being as close to 1.0 as possible.
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Real Time Q-PCR of GPx-1 and Poly-A Polymerase
Real time PCR was performed to measure the relative amount of GPx, the gene of
interest, and Poly-A polymerase, the internal control, mRNA in each of the eight liver samples
and the calibrator. Each reaction consisted of 12.5 µL SYBR Green (Bio-Rad Laboratories, Inc.,
Hercules, CA), 1 µL of sense primer for the gene to be amplified, 1 µL antisense primer for the
gene to be amplified, 9.5µL autoclaved H2O, and 1µL of the cDNA to be amplified for a final
reaction volume of 25 µL per well. Two master mixes were made containing all reactants with
exception of template cDNA, one for each gene of interest, and Q-PCR was performed for both
genes in all samples, including the calibrator. Again, a “no template control” consisting of only
autoclaved water and lacking any template cDNA was also made for both GPx and Poly-A,
which was utilized to ensure that there was no DNA contamination of the reaction. Into each of
ten 0.5 µL microcentrifuge tubes per gene of interest was pipetted 96µL of master mix, followed
by 4µL of sample cDNA, one sample per microcentrifuge tube per gene. The no template
controls each received 4 µL of autoclaved water. The contents of each tube were then pipetted in
triplicate into a 96-well plate, for a total volume of 25 µL per well. The plate was placed into the
MyIQ ThermalCycler (Bio-Rad Laboratories, Inc., Hercules, CA) and a two-step amplification
was performed, as previously discussed in the validation of the Q-PCR reaction.
SYBR Green fluorescence was detected by the MyIQ Reverse Transcription PCR Detection
System (Bio-Rad Laboratories, Inc., Hercules, CA). Data were used to calculate the quantity of
mRNA based on the method for relative quantification in Q-PCR based on previous work by
Pfaffl (2001), in which quantities of mRNA are expressed as n-fold differences relative to a
calibrator. The calibrator used for this experiment consisted of cDNA from the combined liver
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B

C

Figure 3.3. Dilution Ct values, melting curves, and standard curve obtained with primers
for GPx-1 amplification in calibrator sample. Five 10-fold dilutions (undiluted, 1:10,
1:100, 1:1000, and 1:10,000) of calibrator cDNA were used for the generation of (A)
dilution Ct values, (B) melting curves, and (C) a standard curve.
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samples collected from three 21 d old calves considered as baselines, euthanized prior to starting
on a Se-adequate or Se-deficient diet.
Poly-A polymerase was used as the reference gene for all samples, including the calibrator.
Relative transcription values were then calculated by first using the threshold cycle (CT) values
of the reference gene to normalize the target gene signals for each sample, resulting in the ΔCTT
for the target gene and the ΔCTR for the reference gene. The ΔCTT was calculated by subtracting
the CT value for the target gene in the calibrator from the CT value for the target gene in each
sample. Likewise, the ΔCTR was calculated by subtracting the CT value for the reference gene in
the calibrator from that of the reference gene in each sample. The amount of target gene
amplicon relative to the calibrator was then calculated using the following formula:
n-fold difference = Efficiency Target GeneΔCTT / Efficiency Reference GeneΔCTR .
As a result, all mRNA quantities were expressed as the n-fold difference related to the calibrator,
normalized to the reference gene.
Statistical Analysis
Statistical analyses were performed on all data to determine statistical significance.
Response variables of interest were average daily gain (ADG), average daily intake (ADI), liver
tissue Se concentration, RBC-GPx activity, GPx-3 activity, liver GPx-1 mRNA, and relative
liver GPx-1 mRNA n-fold difference. Calf was considered the experimental unit for all analyses
and significance was determined at the 0.05 level. Calf ADG, ADI, RBC-GPx activity, and GPx3 activity were considered to be repeated measures and were analyzed using the Proc Mixed
procedure in SAS (SAS Institute, Cary, SC). Liver tissue Se concentrations, liver GPx-1 activity,
and relative liver mRNA data were treated as a completely randomized ANOVA and were
analyzed using the Proc Mixed procedure of SAS (SAS Institute, Cary, SC). Regression and
correlation analyses were performed on relative mRNA levels, RBC-GPx activity, and GPx-3
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activity using the Proc Reg and Proc Corr procedures of SAS (SAS Institute, Cary, SC),
respectively.
Results and Discussion
Growth and Intake
Supplemental Se inclusion had no effect on ADI at any time during the experiment. The
mean ADI for diet phase 1, which occurred from 28 d of age until 83 d of age, was 1.86 ± 0.07
kg/d. During phase 2, which lasted from 84 d of age until 167 d of age, the mean ADI was 2.88 ±
0.07 kg/d. Average daily intake during phase 3, which lasted from 168 d until trial completion at
180 d of age, was 3.30 ± 0.08 kg/d (Figure 3.4).
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Figure 3.4. Average daily intake (kg/d) by phase for calves fed diets supplemented or
unsupplemented with Se.
Likewise, growth was unaffected by dietary treatment (Figure 3.5), which was in agreement with
findings in previous research in swine, cattle, and poultry (Mahan and Parrett, 1996; Lawler et
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al., 2004; Payne and Southern, 2005). The ADG during phase 1 was 0.65 ± 0.097 kg/d. Average
daily gain during phase 2 was 0.69 ± 0.097 kg/d, while phase 3 ADG was 0.53 ± 0.110 kg/d.
Liver Se Concentration
Liver Se concentration at d 180 of age for baseline calves and calves maintained on the
Se adequate diet were significantly higher than that of calves maintained on the Se-deficient diet,
but liver Se concentration was not different between baseline calves and calves maintained on
the Se-adequate diet. Mean Se concentration in the livers of baseline calves and those maintained
on the Se-adequate diet were 0.800 ± 0.105 ppm and 0.742 ± 0.091 ppm, respectively (dry
weight). Mean Se concentration in the livers of calves maintained on the Se-deficient diet was
0.412 ± 0.091 ppm (dry weight) (Figure 3.6).
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Figure 3.5. Average daily gain (kg/d) by phase for calves fed diets supplemented or
unsupplemented with Se.
The mean liver Se concentration of calves fed the Se-deficient diet was higher than that
reported in 8 wk old lambs by Oh et al. (1976), in which lambs fed a torula yeast-based milk diet
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containing 0.01 ppm Se had an average liver Se concentration of 0.049 ppm Se on a wet basis,
but the mean liver Se concentrations of calves fed the Se adequate diet were similar to lambs fed
the torula-based milk diet supplemented with 0.10 ppm Se. Lambs supplemented with 0.10 ppm
Se were reported as having an average liver Se concentration of 0.183 ppm Se on a wet basis.
Although Se concentration is generally considered to be higher in muscle tissue (Behne
and Wolters, 1983), the concentration of Se in the liver is of considerable importance, as it is
reflective of Se status (Abdelrahman and Kincaid, 1995). This is demonstrated by the 1
comparison of the distribution of Se concentration in various tissues and the distribution of GPxactivity in those same tissues. While muscle and liver tissue have been reported to contain
approximately 39.8 and 31.7% of the Se found in the body respectively, only 6.1 % of GPx-1
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Figure 3.6. Mean liver Se concentration by treatment at d 180 of age.
activity is located within muscle tissue while 65.6 % of GPx-1 activity is located in liver tissue
(Behne and Wolters, 1983). The liver Se concentration of the sampled calves at d 180 of age
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followed the expected trend: calves maintained on the Se adequate diet had, on average, almost
50% higher liver Se concentrations than that of calves maintained on the Se-deficient diet. This
was in agreement with the findings of previous research in which mammals of various species
maintained on Se-deficient diets were shown to have significantly decreased concentrations of
liver Se when compared to that of animals fed a diet adequate in Se (Mahan et al., 1999; Payne
and Southern, 2005; Hostetler et al., 2006). However, the Se concentration of Se adequate and
deficient treatment groups were lower than the expected range noted by Stowe and Herdt (1992),
in which they report the normal liver Se concentration of all species, regardless of age, should be
in the range of 1.2 to 2.0 ppm Se on a dry weight basis. The liver Se concentrations in both Se
adequate and Se-deficient calves were also lower than values reported by Abdelrahman and
Kincaid (1995) in which 42 d old calves born to dams either supplemented with Se via a Se bolus
or unsupplemented with Se had a mean liver Se concentration of 2.62 and 1.20 ppm Se on a dry
weight basis, respectively.
Glutathione Peroxidase-3 and Glutathione Peroxidase-1 Activities
Plasma GPx-3 activity varied considerably between sampling times throughout the
duration of the trial for both treatment groups, but a significant difference (P < 0.05) between
treatments was not detected until d 180 of age. At this time a decrease of approximately 52% in
GPx-3 activity in the Se-deficient group was observed (1.79 ± 0.20 versus 0.86 ± 0.16 EU/g
protein) (Figure 3.7).
The RBC-GPx activity was more reflective of the Se content when compared to GPx-3
activity. While treatment differences in GPx-3 activity were observed on d 180 of age, calves
supplemented with Se had higher RBC-GPx activity at d 84 of age and through trial termination
(P < 0.01). On d 84 of age the mean RBC-GPx activity of calves maintained on the Se adequate
diet was 52.09 ± 4.61 EU/g Hb, while the mean RBC-GPx activity for calves fed the Se-deficient
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diet was 24.47 ± 4.61 EU/g Hb. This represented approximately a 61% decrease in RBC-GPx
activity in those calves maintained on the Se-deficient diet. By d 180 of age the mean RBC-GPx
activity of Se-adequate and Se-deficient calves was 54.98 ± 6.20 and 11.56 ± 4.95 EU/g Hb,
respectively, representing a 79% decrease in GPx-1 activity in calves maintained on the Sedeficient diet (Figure 3.8).
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Figure 3.7. Mean GPx-3 activity of Se supplemented and unsupplemented calves by
day.
As previously discussed, GPx-3 activity is generally considered to be an indicator of

short term Se status. Therefore, the considerable variation observed with respect to the trend in
GPx-3 activity for both groups was expected, as day to day feed intake and hydration status may
have played a role in affecting GPx-3 activity measurements. In addition, Oh et al. (1976)
reported that unlike circulating plasma Se, erythrocytes contain a relatively constant proportion
of total blood Se. However, it was surprising that no detectable decrease in GPx-3 activity
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occurred before d 180 of age, when the first significant decrease in RBC-GPx activity for calves
maintained on the Se-deficient diet was observed by d 84 of age. Erythrocyte GPx-1 activity was
not expected to differ significantly until calves were older, based on the 90 to 120 d whole body
turnover of erythrocytes (Gerloff, 1992); likewise, GPx-3 activity was expected to decrease in Se
deficient calves at an earlier time point than observed. However, the seemingly early decrease in
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Figure 3.8. Mean erythrocyte GPx-1 activity of Se supplemented and unsupplemented
calves by day.
RBC-GPx activity may be explained by considering that RBC-GPx is incorporated into
erythrocytes during erythropoiesis (Gerloff, 1992). The time at which the first difference in
RBC-GPx activity was observed between treatments actually approximates the half-life of
bovine erythrocytes (Oh et al., 1976; Gerloff, 1992) and RBC-GPx activities were analyzed as a
mean of all calves within a treatment group. In addition, the considerable variation observed
with respect to GPx-3 activity may also be explained as a function of the fact that GPx-3 is
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considered a short-term indicator of Se status (Gerloff, 1992). Although calves were limit-fed
with regard to the amount of ration they received at each feeding, they were not limited in the
amount of time allowed to consume the ration. Not all calves were observed to eat at the same
rate; it is possible that calves consuming the ration slowly throughout the day might have
maintained higher, more consistent plasma Se levels and therefore higher GPx-3 activity levels if
sampled shortly after consuming feed, affecting the overall trend in GPx-3 activity.
Plasma GPx activity for both treatment groups was in agreement with GPx-3 activities
previously reported by Rowntree et al. (2004) in beef cows, in which cows either receiving no
supplemental Se or a 20 mg Se drench per day had an average GPx-3 activity of 0.92 and 1.34
EU/g protein, respectively. The decrease in GPx-3 activity observed in calves maintained on the
Se-deficient diet were in agreement with previous reports in various species in which animals
were fed either a diet adequate or deficient in Se, although the actual amounts of GPx-3 activity
varied considerably from species to species (Weiss et al., 1996; Lei et al., 1998; Enjalbert, 1999;
Mahan et al., 1999).
The trend observed in RBC-GPx activity occurred as expected, with Se adequate calves
maintaining a relatively constant RBC-GPx activity while the RBC-GPx activity of Se-deficient
calves decreased over time. The RBC-GPx activity for both treatment groups supported previous
research in which animals maintained on a Se-deficient diet were reported to have significantly
decreased RBC-GPx activity levels when compared to animals of the same species maintained
on a Se adequate diet. Oh et al. (1976) reported that lambs maintained on a Se-deficient artificial
milk diet had RBC-GPx activity levels that were significantly decreased (P < 0.01) when
compared to that of lambs maintained on a diet supplemented with 0.1 ppm Se. Weiss et al.
(1996) reported that female rats maintained on a Se-deficient basal diet containing 0.007 ppm Se
had an average RBC-GPx activity that was only 40% of the activity observed in rats maintained
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on the basal diet supplemented with 0.1 ppm Se as sodium selenite. Rowntree et al. (2004)
reported that pregnant beef cows either unsupplemented with Se or supplemented with a 20 mg
Se drench had RBC-GPx activity levels of 14.94 EU/g Hb and 24.61 EU/g Hb, respectively,
although these activities were actually somewhat lower than those found in our research using
neonatal Holstein calves.
Liver GPx-1 activity on d 180 of age was not affected by dietary treatment (P= 0.581).
The average liver GPx-1 activities for Se adequate and Se-deficient groups were 2079.33 ±
943.20 and 2553.13 ± 816.84 EU/g protein, respectively, while that of the baseline calves was
3241.25 ± 943.2 EU/g protein (Figure 3.9). The liver GPx-1 activity of both the Se adequate and
baseline groups was a mean of the activities from three calves, while the activity of the Sedeficient group was the mean of four calves. A calf in the Se adequate group was removed from
the analysis as it was determined to be an outlier.
These findings are not in agreement with any literature currently available. Oh et al.
(1976) reported a significant increase (P < 0.01) in the liver tissue GPx-1 activity of 8 wk old
lambs fed a torula yeast-based artificial milk diet supplemented with either 0.05 or 0.1 ppm Se,
versus lambs fed the same diet unsupplemented with Se. Likewise, Whanger and Butler (1988)
reported that rats fed a Se-deficient basal diet containing 0.02 ppm Se had an average liver GPx1 activity of 8 ± 4 EU/g protein, representing 1.1% of the activity observed in rats maintained on
the basal diet supplemented with 0.2 ppm Se as sodium selenite. Furthermore, Weiss et al.
(1996). reported female rats maintained on a basal diet containing 0.007 ppm Se had an average
liver GPx-1 activity that was only 2 ± 1% of the activity observed in female rats maintained on
the basal diet supplemented with 0.1 ppm Se as sodium selenite. It was considered that perhaps
the liver GPx-1 activity response in larger mammals was not as profound as that observed in rats,
but Lei et al. (1998) reported that pigs fed a diet containing 0.03 ppm Se had an average liver
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GPx-1 activity of 12.5 EU/g protein, whereas pigs maintained on the basal diet supplemented
with 0.3 ppm Se had an average liver GPx-1 activity of 210 EU/g protein, representing a 94%
decrease in liver GPx-1 activity in pigs fed the Se-deficient diet.
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Figure 3.9. Mean liver GPx-1 activity of 21 d old baseline calves, and Se supplemented,
and Se unsupplemented calves on d 180 of age.
Glutathione S-transferase (GST; EC 2.5.2.18) activity was considered as a possible

explanation for the unexpected results obtained in this study. Glutathione S-transferase is a Seindependent glutathione peroxidase (Burk, 1983) associated with the reduction of certain organic
hydroperoxides (Ullrey, 1987). These GST enzymes have been reported to be most active in
tissues such as brain, liver, kidneys, adrenals, and testes, while tissues such as spleen, muscle,
lungs, erythrocytes, thymus, and plasma have relatively little or no GST activity associated with
them (Behne and Wolters, 1983). Research has shown that the use of organic hydroperoxides
such as cumene hydroperoxide in the assay of GPx-1 activity in some tissues may result in
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falsely elevated GPx-1 activity levels, especially in tissues of animals maintained on Se-deficient
diets (Lawrenece and Burk, 1976). In fact, Lei et al. (1998) reported that GST activity for pigs
fed a Se-deficient basal diet containing 0.03 ppm Se or the basal diet supplemented with either
0.1 or 0.3 ppm Se as sodium selenite had liver GST activities of 513.4, 448.9, and 264.6 nmol S2,4-dinitrophenylglutathione per min per mg protein, respectively. This finding supported
previous research in which it was determined that GST activity was induced by Se deficiency
(Christensen et al., 1994; Cheng et al., 1997). However, GST cannot catalyze the reduction of
H2O2. For this reason, when liver GPx-1 activity assays were performed for this experiment,
H2O2 was used as the substrate in order to eliminate the accidental assay of GST and
overestimation GPx-1 activity. Catalase, an iron-requiring peroxidase enzyme, could have
contributed to the overestimation of GPx-1 activity in the liver samples from Se-deficient calves.
However, two catalase inhibitors, sodium azide (NaN3) and cyanide contained in Drabkin’s
Reagent, were thus added to the reaction to inhibit the activity of this enzyme.
Most likely, the small sample size of calves euthanized for collection of liver samples
played a part in both the unusually high standard error of the mean and the unexpected results
observed regarding liver GPx-1 activity. In addition, calves were only sampled once, at trial
termination, due to the large amount of tissue required for determination of liver Se
concentration, liver GPx-1 activity, and liver GPx-1 mRNA relative transcript level analysis. We
hypothesize that sampling of calves for liver samples at 28 d intervals, as was performed in the
collection of blood and plasma, may be beneficial in obtaining a more realistic picture of liver
GPx-1 activity over time. This might be accomplished in the future by performing liver biopsies
for collection of liver tissue at pre-determined intervals in lieu of euthanizing calves.
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Liver GPx-1 mRNA Transcript Levels
Relative liver GPx-1 mRNA transcript level on d 180 of age was significantly higher (P<
0.05) for the Se adequate group. On average, Se adequate calves had a relative mRNA level that
was approximately 30% greater than the level of mRNA expression in baseline calves, while Sedeficient calves had approximately a 45% decrease in average relative mRNA level when
compared to that of baseline calves. The difference in mRNA transcript level of the Se adequate
treatment group versus the Se-deficient treatment group was considered to be significant. (Figure
3.10).
These observations are in agreement with previous research examining the effect of Se
deficiency on relative liver GPx-1 transcript levels, although the extent to which the GPx-1
mRNA levels decreased varied among species. Weiss et al. (1996) reported that GPx-1 mRNA
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Figure 3.10. Relative GPx-1 mRNA transcript levels of baseline, Se supplemented, and
Se unsupplemented calves expressed as n-fold differences.
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levels normalized to 18S rRNA of female rats fed a basal diet containing 0.007 ppm Se were 17
± 4% of those found in rats fed the basal diet supplemented with 0.1 ppm Se. Lei et al. (1998)
determined that liver GPx-1 mRNA levels of pigs fed a Se-deficient basal diet containing 0.03
ppm Se were significantly lower (P< 0.05) than that of pigs maintained on the basal diet
supplemented with 0.1 or 0.3 ppm Se as sodium selenite. However, these findings are not in
agreement with those of Hostetler et al. (2006), in which sows fed a Se-deficient diet containing
0.05 ppm were found to have no significant decrease (P > 0.05) in liver GPx-1 mRNA level
when compared to sows consuming a diet containing 0.39 ppm Se. Based on these results, calves
in our study maintained on the Se-deficient diet may not have achieved severe Se deficiency. To
our knowledge this is the first report of the effect of Se deficiency on relative liver GPx-1 mRNA
transcript levels in the bovine.
Regression analyses were performed to determine the relationship between GPx-1 mRNA
transcript level and both RBC-GPx and GPx-3 activity. There was a positive linear relationship
between liver GPx-1 mRNA n-fold difference and RBC-GPx activity (Adjusted r2= 0.47; r2=
0.58; Figure 3.11). There was also a positive linear relationship between GPx-1 mRNA n-fold
difference and GPx-3 activity (Adjusted r2= 0.76; r2= 0.81; Figure 3.12).
Correlation analyses were also performed to determine the extent of the relationship
between the variables in each of the regression analyses. Erythrocyte GPx-1 activity and GPx-1
mRNA n-fold difference were moderately correlated, with a Pearson’s Correlation Coefficient of
0.70. Interestingly, GPx-3 activity and GPx-1 mRNA n-fold difference were highly correlated,
with a Pearson’s Correlation Coefficient of 0.90.
The positive linear relationship observed between liver GPx-1 mRNA levels and both
RBC-GPx and GPx-3 were expected, as GPx mRNA transcript level is expected to increase
sigmoidally in response to Se supplementation (Weiss et al., 1996), while both RBC-GPx and
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GPx-3 activities increase with increasing Se supplementation until reaching a specific plateau
point (Weiss et al., 1996; Lei et al., 1998). However, the strength of both the linear relationship
and the correlation coefficient for GPx-1 to GPx-1 mRNA levels was unexpected, as these were
higher for GPx-3 than they were for RBC-GPx. It is currently unclear as to whether or not the
strength of these relationships is truly significantly greater than that for the relationship between
RBC-GPx and GPx-1 mRNA levels. It is possible that sampling calves for liver GPx-1 mRNA
transcript level at only one time point, d 180 of age,
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Figure 3.11. Regression analysis of relative GPx-1 mRNA n-fold difference and
erythrocyte GPx-1 activity (Adjusted r2=0.47; r2= 0.58).

65

70

1. 8

n_f ol d_di f f er ence = - 0. 1387 +0. 6755 gpx3

1. 6
1. 4
1. 2
1
0. 8
0. 6

n-fold difference = -0.1387 + 0.6755 GPx-3
0. 4
0. 75

1

1. 25

1. 5

1. 75

2

2. 25

2. 5

2. 75

3

gpx3protein
GPx-3, EU/g

Figure 3.12. Regression analysis of relative GPx-1 mRNA n-fold difference and GPx-3
activity (Adj r2= 0.76; r2= 0.81).
only provided a partial picture of the ongoing relationship between RBC-GPx activity and
subsequent mRNA levels. We hypothesize that liver biopsy and sampling of blood and plasma to
obtain samples at consistent intervals may provide a clearer determination of the relationship
between liver GPx-1 mRNA transcript levels and enzyme activities.
Conclusions
The goal of this research was to establish a range of values for RBC-GPx and GPx-3
activities, as well as for liver Se concentration of neonatal and growing Holstein calves until
approximately d 180 of age. These specifications are particular to our laboratory based on the
type of research we wish to perform in the future; thus it was considered pertinent to establish
reference values for our own use. Secondly, we investigated the effect of Se deficiency on
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relative GPx-1 mRNA transcript levels in the 180 d old bovine calf. To our knowledge, there is
currently no such research in publication.
The utilization of semi-purified and purified diets for the purpose of inducing Se
deficiency is often very costly, especially in the feeding of large animals. It may be beneficial in
the future to determine the minimal length of time required for the feeding of such diets to obtain
Se deficiency, in order to minimize the amount of time animals must be maintained on such
diets. The use of RBC-GPx or GPx-3 activity as an indicator of Se status in the growing Holstein
calf may prove to be a valuable tool; however, determination of serial erythrocyte and plasma Se
concentrations is necessary to truly establish the GPx activity level at which circulating Se levels
may be considered deficient. In addition, determination of serial liver Se concentrations may
prove equally beneficial, as liver Se concentration is generally considered the most accurate
indicator of Se status.
The quantification of bovine GPx-1 mRNA in the liver of growing calves may also
contribute to the current understanding of the effect of Se supplementation and deficiency on
liver GPx-1 gene expression in the bovine. Considerable research on this subject has been
performed in rats and, to a lesser extent, pigs, but very little information is available in for cattle.
Understanding the effects of Se deficiency at the molecular level may provide valuable insight
into the nature of selenium’s role in health and immunity. However, our research is only a
starting point; questions remain to be answered regarding the specific biology of Se in the
ruminant animal. Important comparisons remain to be made between the biology of Se on the
molecular level in the ruminant animals versus other large animal species. Trials with larger
sample sizes utilizing serial sampling of liver and other tissues such as the tissues from the
kidney may be beneficial in furthering our understanding concerning the role of Se in health on a
molecular level.
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There is still considerable information that remains to be learned concerning selenium as
a micronutrient integral in oxidant status and the proper functioning of the immune system. Basic
research is required to increase our understanding of antioxidants in immunity and health, both
on the cellular level and with regards to the body as a whole.
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APPENDIX A: PROTOCOLS
PLASMA AND ERYTHROCYTE COLLECTION PROTOCOL
Blood Collection
1. Collect approximately 10 mL whole blood via jugular veinipuncture in 10 mL
vaccutainer tube (BD Vacutainer Systems, Franklin Lakes, NJ) containing sodium
heparin to keep blood from clotting.
2. Mix blood and heparin together by gently inverting tube 3 or 4 times post-draw.
3. Store collected sample on ice until processing.
Blood Processing
1. Centrifuge vaccutainer tubes for 15 min at 2,000 x g at 4º C.
2. After centrifugation, remove plasma layer by pipetting with a disposable pipet and
store plasma in a 5 mL Falcon tube (BD Biosciences, San Jose, CA). Avoid removing
white buffy layer from the surface of erythrocytes. Store plasma at -80º C until assay.
3. Remove white buffy layer from surface of erythrocyte layer and discard.
4. Wash erythrocytes by adding approximately 6 mL of ice cold phosphate buffered
saline. Mix by gentle inversion and centrifuge at 2,000 x g at 4º C for 15 min.
5. Remove resulting supernatant and discard.
6. Repeat steps 5 and 6 two more times, for a total of three washings.
7. Following the last wash, pipet approximately 0.5 to 1.0 mL of erythrocytes into a 1.5
mL microcentrifuge tube. Freeze erythrocytes at -80º C until assay.
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GLUTATHIONE PEROXIDASE ACTIVITY ASSAY PROTOCOL
Pre-Assay Preparation
A. Assay Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5 mM EDTA)
1. Dilute 2 mL assay buffer concentrate, provided in the Cayman Chemical GPx
Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), with 18
mL of HPLC-grade water.
2. Store diluted buffer at 4º C for no longer than one month.
B. Sample Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5mM EDTA, 1 mg/mL BSA)
1. Dilute 2 mL of sample buffer concentrate, provided in the Cayman Chemical
GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI),
with 18 mL of HPLC-grade water. This buffer should be used to dilute the
samples prior to assaying.
2. Store diluted buffer at 4º C for no longer than one month.
C. Dilution of Bovine Glutathione Peroxidase
1. Make two 10.5 µL aliquots of Bovine GPx, supplied in the Cayman Chemical
GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), and
store in a 0.5 mL microcentrifuge tube at -20º C.
2. Immediately prior to use, pipet 10 µL of the Bovine GPx to a 1.5 mL
microcentrifuge tube and dilute with 490 µL Sample Buffer. Store on ice until
assay. The diluted enzyme is stable for four hours on ice.
D. Co-Substrate Mixture (lyophilized NADPH, glutathione, and glutathione reductase)
1. Reconstitute each vial by adding 2ml of HPLC-grade water to each vial
containing Co-Substrate Mixture and vortex well. The reconstituted agent
should be kept at 25ºC while assaying.
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2. The reconstituted mixture should be stored at 4º C and is stable for 2 days.
Reconstituted mixture should not be frozen.
Sample Preparation
Plasma and Erythrocyte Lysate
1. Plasma stored at -80 ºC must be thawed on ice prior to assay. No further
dilutions are necessary.
2. Erythrocytes must be lysed by diluting 1:4 in ice cold HPLC-grade water.
3. Dilute erythrocytes 1:400 by adding 2 µL of lysed erythrocytes to 198 µL of ice
cold sample buffer. Store dilutions at -80 ºC until assay.
4. Thaw frozen erythrocyte 1:400 dilutions on ice for assay.
Performing the Assay
1. Plate Set-up
A. Background or non-enzymatic wells: add 120µl of assay buffer and 50µl of cosubstrate mixture to three wells.
B. Positive Control wells (bovine erythrocyte GPx): add 100µl of assay buffer,
50µl of co-substrate mixture, and 20µl of diluted GPx (control) to three wells.
C. Sample wells: add 100µl of assay buffer, 50µl of co-substrate mixture, and
20µl of sample to three wells.
2. Allow plate to sit for 5 min to come to room temperature.
3. Initiate the reactions by adding 20µl of cumene hydroperoxide to all the wells being
used. Make sure to note the precise time the reaction is initiated and add the cumene
hydroperoxide as quickly as possible.
4. Carefully shake the plate for a few s to mix.
5. Incubate plate at 25º C in plate reader.
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6. Read the absorbance once every min for six at 340nm using a plate reader to obtain
7 absorbance reads.
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GPX ASSAY KIT PROTOCOL FOR DETERMINATION OF LIVER GPX
Pre-Assay Preparation
A. Assay Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5 mM EDTA)
1. Dilute 2 mL assay buffer concentrate, provided in the Cayman Chemical GPx
Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), with 18
mL of HPLC-grade water.
2. Store diluted buffer at 4º C for no longer than one month.
B. Sample Buffer (10x, 50 mM Tris-HCL, pH 7.6, 5mM EDTA, 1 mg/mL BSA)
1. Dilute 2 mL of sample buffer concentrate, provided in the Cayman Chemical
GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI),
with 18 mL of HPLC-grade water. This buffer should be used to dilute the
samples prior to assaying.
2. Store diluted buffer at 4º C for no longer than one month.
C. Dilution of Bovine Glutathione Peroxidase
1. Make two 10.5 µL aliquots of Bovine GPx, supplied in the Cayman Chemical
GPx Activity Assay Kit (Cayman Chemical Corporation, Ann Arbor, MI), and
store in a 0.5 mL microcentrifuge tube at -20º C.
2. Immediately prior to use, pipet 10 µL of the Bovine GPx to a 1.5 mL
microcentrifuge tube and dilute with 490 µL Sample Buffer. Store on ice until
assay. The diluted enzyme is stable for four hours on ice.
D. Co-Substrate Mixture (lyophilized NADPH, glutathione, and glutathione reductase)
1. Reconstitute each vial by adding 2ml of HPLC-grade water to each vial
containing Co-Substrate Mixture and vortex well. The reconstituted agent
should be kept at 25ºC while assaying.
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2. The reconstituted mixture should be stored at 4º C and is stable for 2 days.
Reconstituted mixture should not be frozen.
E. Double Strength Drabkin’s Reagent (24 mM sodium bicarbonate, 1.6 mM potassium
cyanide, 1.2 mM potassium ferricyanide)
1. Dissolve all solid reagents in distilled H2O (see Appendix B, Double Strength
Drabkin’s Reagent). Store at 25º C.
F. 0.01 M Sodium Azide
1. Dissolve solid reagents in 100 mL distilled H2O (see Appendix B, 0.01 M
Sodium Azide).
G. 12 mM Hydrogen Peroxide (see Appendix B, 12 mM Hydrogen Peroxide)
Sample Preparation
Tissue Homogenate
1. Prior to dissection, perfuse tissue with phosphate buffered saline. Snap freeze
tissue in liquid nitrogen and store at -80º C until assay.
2. Grind the tissue into a fine powder using a mortar and pestle under liquid
nitrogen. Do not allow tissue to thaw.
3. Weigh approximately 1 g tissue into a 14 mL Falcon tube ((BD Biosciences,
San Jose, CA). Into the tube add 10mL cold buffer (50 mM Tris-HCL, pH 7.5,
5 mM EDTA, and 1 mM DTT) per gram of tissue.
4. Centrifuge at 10,000 x g for 15 min at 4ºC.
5. Remove the supernatant for assay and pipet into another 14 mL Falcon tube
(BD Biosciences, San Jose, CA). Make one 1.5 mL aliquot and freeze both at
-80ºC. The sample will be stable for at least 1 month.
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Performing the Assay
1. Plate Set-Up
A. Background or non-enzymatic wells: add 90µl of assay buffer, 50µl of cosubstrate mixture, 20µl of Drabkin’s Reagent, and 10µl sodium azide to each of
three wells.
B. Positive Control wells (bovine erythrocyte GPx): add 70µl of assay buffer,
50µl of co-substrate mixture, 20µl of Drabkin’s reagent, 10µl of sodium azide,
and 20µl of diluted GPx (control) to three wells.
C. Sample wells: add 70µl of assay buffer, 50µl of co-substrate mixture, 20µl of
Drabkin’s reagent, 10µl of sodium azide, and 20µl of sample to three wells.
2. Initiate the reactions by adding 20µl of 12 mM hydrogen peroxide to all the
wells being used. Make sure to note the precise time the reaction is initiated
and add the hydrogen peroxide as quickly as possible.
3.Allow plate to sit for 5 min to come to room temperature
4. Carefully shake the plate for a few s to mix.
5. Incubate the plate at 25º C in the plate reader for the duration of the assay.
6. Read the absorbance once every min at 340nm using a plate reader to obtain
at least 5 time points.
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CALCULATION OF GLUTATHIONE PEROXIDASE ACTIVITY ASSAY RESULTS
1. Determine the change in absorbance (ΔA340) per min by:
a. Plotting the absorbance values as a function to obtain the slope (rate) of the
linear portion of the curve –orb. Select two points on the linear portion of the curve and determine the change in
absorbance during that time using the following equation:
ΔA340/min = A340 (Time 2) – A340 (Time 1)/ Time 2 (min) – Time 1 (min)
2. Determine the rate of ΔA340/min for the background or non-enzymatic wells and
subtract this rate from that of the sample wells.
3. Use the following formula to calculate the GPx activity. The reaction rate at 340nm
can be determined using the NADPH extinction coefficient of 0.00373 µM-1. One
unit is defined as the amount of enzyme that will cause the oxidation of 1.0 nmol of
NADPH to NADP per min at 25ºC.
GPx activity = [(ΔA340/min)/0.00373µM-1] x (0.19ml/0.02ml) x sample dilution = nmol/min/ml

88

BRADFORD PROTEIN ASSAY PROTCOL
Preparation of Standard Curve with 2 mg/mL BSA
1. Prepare standards in 1.5µL microcentrifuge tubes. Prepare standard dilutions using 2
mg/mL BSA (Bio-Rad Laboratories, Inc., Hercules, CA) according to table A.1.:

Table A.1. Standard curve dilution preparation with 2 mg/mL BSA.

Tube #
1
2
3
4
5
6
7
8 (blank)

Standard
volume (µL)

Source of
Standard

Diluent
Volume (µL)

70
75
70
35
70
70
70
---

2 mg/mL stock
2 mg/mL stock
2 mg/mL stock
Tube 2
Tube 3
Tube 5
Tube 6
---

0
25
70
35
70
70
70
70

Final
[Protein],
ng/mL
2,000
1,500
1,000
750
500
250
125
0

2. Pipette 20 µL from each microcentrifuge tube into each of three clean, dry cuvettes (curve
is constructed in triplicate).
3. Add 1mL Coomassie Blue dye (Bio-Rad Laboratories, Inc., Hercules, CA) to each cuvette.
4. Allow cuvettes to incubate for at least 5 min. Samples should not be incubated for
longer than 1 hour at room temperature.
5. Use blank to zero the spectrophotometer. Select standard curve set-up procedure on the
spectrophotometer. Enter # of standards, # or replicates per standard (3), and enter
standard concentrations when prompted.
6. Print out results and save in spectrophotometer.
Standard 1 mL Assay with Coomassie Brilliant Blue G-250
1. Remove 1x Coomassie Brilliant Blue (Bio-Rad Laboratories, Inc., Hercules, CA ) dye
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reagent from 4ºC storage and allow it to warm to ambient temperature. Invert the 1x
dye reagent a few times before use.
2. Prepare sample dilutions in glass-filtered water. Plasma samples require 1:50 dilution.
Liver tissue hemolysate samples require 1:10 dilution.
3. Pipet 20 µL of each unknown sample solution into separate clean cuvettes. Add 1 mL
of 1x Coomassie Blue dye (Bio-Rad Laboratories, Inc., Hercules, CA) to each cuvette
and invert.
4. Incubate at room temperature for at least 5 min. Samples should not be incubated
longer than 1 hour at room temperature.
5. The absorbance wavelength is 595nm. Before analyzing samples, zero the
spectrophotometer with the blank sample. Blank sample consists of 20µL glass-filtered
water and 1 mL Coomassie Brilliant Blue dye (Bio-Rad Laboratories, Inc., Hercules,
CA).
6. Measure the absorbance of the unknown samples, using the pre-saved standard curve
made prior to running the samples for comparison calculations.

.

90

QUANTICHROMTM HEMOGLOBIN ASSAY KIT PROTOCOL
1. 96-Well plate set-up
A. Blank and standard wells.
Pipette 50 μl water (for blank) and 50 μl standard (for standard) into wells of a
clear bottom 96-well plate. Transfer 200 μl water into the blank and standard
wells.
B. Sample wells.
Blood samples should be diluted 100-fold in distilled water (n=100).
Transfer 50 μl samples into wells in triplicate per sample. Avoid bubble formation
during the pipetting steps.
2. Add 200 μl Reagent to sample wells and tap plate lightly to mix.
3. Incubate 5 min at room temperature. Read OD at 400 nm. Signal is
stable for at least 2 hours.
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LIVER mRNA ISOLATION PROTOCOL
Pre-isolation Set-up
1. Bring all buffers except Tris-HCl to room-temperature prior to use.
2. Resuspend Dynabeads Oligo(dT)25 (Dynal Biotech, Inc., Lake Success, NY, USA)
fully before use by gentle pipetting.
4. Pre-heat a water bath to 75°C.
5. Prepare individual aliquots of all buffers and reagents required for reaction prior to
RNA isolation procedure.
6. Prepare Dynabeads Oligo(dT)25 (Dynal Biotech, Inc., Lake Success, NY, USA) for
isolation procedure.
a. Transfer 250µl of beads from the stock tube to a RNase-free 1.5ml
microcentrifuge tube and place the tube on a magnet.
b. After 30 s (or when the suspension is clear) remove the supernatant.
c. Remove the vial from the magnet and wash the beads by resuspending in 250µl
of fresh Lysis/Binding buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10
mM EDTA, 1% lithium dodecylsulfate, 5 mM dithiothreitol).
d. When the sample lysate is ready for combination with the beads, place the tube
on the magnet and remove the lysis/binding buffer after 30 s (or when
the suspension is clear).
Preparation of Lysate from Liver Tissue
1. Weigh and handle the animal tissue while frozen to avoid RNA degradation. Do not
exceed the specified amount of tissue, as using too much tissue will reduce the
mRNA yield and purity.
2. Treat clean, autoclaved mortar and pestle with RNase-Zap to remove trace RNases.
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3. Freeze the microcentrifuge tube into which the ground tissue will be placed by
placing it in dry ice. Weigh the frozen microcentrifuge tube, using it to zero the scale,
and replace the tube in dry ice.
4. Pre-freeze the mortar and pestle in liquid nitrogen prior to adding tissue. Grind frozen
tissue in liquid nitrogen. Work quickly.
5. Transfer the frozen powder to the microcentrifuge tube. Quickly add 1250µL
Lysis/Binding Buffer to tube/sample and homogenize for 1 to 2 min until complete
lysis is obtained. Rapid lysis in the Lysis/Binding Buffer is critical for obtaining
undegraded mRNA.
6. Shear the DNA by forcing the lysate 3-5 times through a 21 gauge needle using a 12ml syringe. Use force.
7. Centrifuge the lysate for 30-60 s at approximately 10,000 x g to remove debris and
reduce foaming after shearing.
8. Transfer the lysate to the tube containing the prepared Dynabeads.
RNA Isolation Procedure
1. Mix the beads with the sample lysate and incubate with continuous mixing on roller
mixer for 3-5 min at room temperature to allow the Poly-A tail of the mRNA to
anneal to the oligo-dT on the beads.
2. Place the vial on the magnet for 2 min and remove the supernatant. Place supernatant
into a clean RNase-free 1.5ml microcentrifuge tube and place on ice.
3. Wash the beads/mRNA complex two times with 2ml of Washing Buffer A ( 10 mM
Tris-HCl, pH 8.0, 150 mM LiCl, 1mM EDTA, 0.1% lithium dodecylsulfate) at room
temperature. Use the magnet to separate the beads from the solution between each
washing step, removing the tube from the rack prior to adding washing buffer each
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time. Fully resuspend the Dynabead/mRNA complex at each washing by short, gentle
vortexing or pipetting
4. Wash the beads/mRNA complex once with 1-1.5ml Washing Buffer B (10 mM TrisHCl, pH 8.0, 150 mM LiCl, 1 mM EDTA) at room temperature. Be sure to fully
resuspend the beads in the washing buffer by gently vortexing or pipetting. Use the
magnet to separate the beads from the solution.
5. To elute the beads, add 25µl 10mM Tris-HCl (Elution Buffer), ensuring that the
beads are completely resuspended in solution by gentle pipetting, and incubate at 6580°C for 2 min. Place the tube immediately on the magnet and transfer the
supernatant containing the mRNA to a new RNase-free tube. Place the mRNA
immediately on ice.
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cDNA SYNTHESIS PROTOCOL
1. Mix 4 µL of iScript reaction mix, 1 µL of reverse transcriptase, and 5 µL of autoclaved water.
2. Make master mixes when possible.
3. Add 10 µL of mRNA sample.
4. Extra mix should be prepared for the no mRNA template negative control.
5. Total volume mix should be 20 µL.
6. Place the mix in the thermocycler.
7. Run the thermocycler at 25ºC for 5 min, 42 ºC for 30 min, denaturation at 85 ºC for 5
min, and a final hold at 4 ºC.
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REVERSE TRANSCRIPTASE PCR PROTOCOL
1. Mix 5 µL of 10X PCR buffer, 1 µL dNTP mix (Appendix B), 2 µL Jump Start TM REDTaq TM
DNA Polymerase (Sigma-Aldrich, Inc., St. Louis, MO, USA) and 39 µL water. Add 1 µL of each 20

ρmol primer. Make a larger volume for multiple samples when appropriate (Master Mix;
Appendix B, rtMM).
2. Add 1 µL of the cDNA sample to each of the master mixes containing the 20 ρmol primers.
3. Prepare enough of each master mix, both the mix without the 20 ρmol primers and the mix
with the primers added, for the negative control, into which no cDNA will be added.
4. Place the sample into the thermocycler.
5. Run one cycle of 1 min at 95ºC; 35 cycles of PCR (95 ºC for 30 s, 56 ºC for 30
s, and 72 ºC for 30 s); followed by 72 ºC for 4 min with a final hold
temperature of 4 ºC.
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QUANTITATIVE PCR PROTOCOL
1. Mix 12.5 µL of iQ SYBR TM Green 2X Supermix (Bio-Rad Laboratories, Inc., Hercules, CA,
USA), 1 µL of 20 ρmol Primer 1, 1 of 20 ρmol µL of Primer 2, and 9.5 µL autoclaved water
for each well.
2. A master mix should be formulated for each gene of interest (Master Mix; Appendix B,
bGPxMM or PaMM).
3. Prepare enough master mix to run both the calibrator and negative controls containing no
cDNA for each gene of interest.
4. Pipette 96 µL of bGPxMM into one 0.5 mL microcentrifuge tube for each sample
(calf)/calibrator/NT control.
5. Add 4 µL cDNA/calibrator/H2O for NT control to the corresponding microcentrifuge tube
containing 96 µL bGPxMM.
6. Pipette 96 µL of PaMM into one 0.5 mL microcentrifuge tube for each sample
(calf)/calibrator/H2O for NT control.
7. Add 4 µL cDNA/calibrator/H2O for NT control to the corresponding microcentrifuge tube
containing 96 µL PaMM.
8. Pipette 25 µL from each sample for each gene of interest into each of three wells.
9. Place the 96-well plate into the thermocycler.
10. Run one cycle of 3 min at 95ºC; 40 cycles of PCR (95 ºC for 10 s and 56 ºC for 45
s); a melting curve consisting of 95 ºC for 1 min followed by 55 ºC for 1 min, a
step cycle with 0 repeats starting at 55 ºC for 10 s with a +0.5 ºC/s transition rate;
and a final hold at 4 ºC.
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GENE EXPRESSION QUANTIFICATION PROTOCOL
1. Use the method described by Pfaffl (2001).
2. Use the combined cDNA from the baseline calves (Materials and Methods) as the calibrator
for the target genes. The same calibrator should be used throughout all the experiments and
plates.
3. Use Poly-A polymerase as the endogenous control gene.
4. Obtain efficiencies by performing a 10-fold dilution standard curve on all genes of interest,
both the reference and target genes, prior to analysis.
5. Use the signal of the reference gene Poly-A to normalize the target gene signals of each
sample by subtracting the average CT value of Poly-A from that of the target gene.
6. Calibrate the ΔCT for gene transcription against the sample used as the calibrator. Calculate
both a ΔCTT for the target gene and a ΔCTR for the reference gene.
a. Calculate the ΔCTT by subtracting the CT value for the target gene in the calibrator
from the CT value for the target gene in each sample.
b. Calculate the ΔCTR by subtracting the CT value for the reference gene in the calibrator
from that of the reference gene in each sample.
7. Calculate the relative linear amount of target molecules relative to the calibrator by using the
following equation:
n-fold difference = Efficiency Target GeneΔCTT / Efficiency Reference GeneΔCTR
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APPENDIX B: BUFFER AND STOCK PREPARATIONS
PHOSPHATE BUFFERED SALINE a
Component

Product No.

Sodium Chloride

a

S271-500

Company

Amount
80.0 g

11.5 g
2.0 g

Potassium Chloride

PX1405-CB607

Sodium Phosphate
Potassium
Phosphate
ddH2O

7917-1

Fischer Scientific
Matheson
Coleman and
Bell
Mallinckrodt

P0662-500G

Sigma

-

-

2.0 g

1000 mL

10X concentrate. Store at 4ºC. Dilute to 1:10 in ddH2O for use in washing cells and
perfusing tissue.

TISSUE HOMOGENATION BUFFER a
Component

Product No.

Company

Final mM

mL, mg / 250 mL

1 M Tris-HCl, pH 7.5

15567-027

Invitrogen

50

12.5

EDTA

JT8993-1

JT Baker

5

465.3

D-1532

Invitrogen

1

38.5

-

-

-

237.5

Dithiothreitol
ddH2O
a

DTT has short half-life. Use immediately; do not store!

DOUBLE STRENGTH DRABKIN’S REAGENT
Component
Sodium
Bicarbonate
Potassium
Cyanide
Potassium
Ferricyanide
dd H2O

mL, mg / 100
mL

Product No.

Company

Final mM

S6014-25G

Sigma-Aldrich

24

200

60178-25G

Sigma Aldrich

1.6

10.4

244023-5G

Sigma-Aldrich

1.2

39.6

-

-

-

100
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0.01 M SODIUM AZIDE SOLUTION
mL, mg / 100 mL

Component

Product No.

Company

Sodium Azide

S8032-25G

Sigma-Aldrich

65

-

-

100

ddH2O

12 mM HYDROGEN PEROXIDEa,b
Component
30% H2O2, w/w
ddH2O
a
b

Product No.

Company

mL/100 mL

216763-100ml

Sigma-Aldrich

0.124

-

-

99.876

Store capped in dark vial at 4º C.
Decant small amount into separate vial for each assay.

iSCRIPT REVERSE TRANSCRIPTASE cDNA SYNTHESIS MIX
Component

Product No.

Company

Amount

iScript Reaction Mix

170-8891

BioRad

4 µL

Reverse Transcriptase

170-8891

BioRad

1 µL

mRNA

-

-

10 µL

Autoclaved H2O

-

-

5 µL

dNTP MIX a
Component

Product No.

Company

dATP

1-969-064

Roche

10 µL

dCTP

1-969-064

Roche

10 µL

dGTP

1-969-064

Roche

10 µL

dTTP

1-969-064

Roche

10 µL

-

-

60 µL

Autoclaved H2O
a

Store at -20ºC for 2 to 3 months
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Amount

REVERSE TRANSCRIPTION PCR MASTER MIX (rtMM)
Component

Amount
(Per Sample)

Product No.

Company

Autoclaved H2O

-

-

39 µL

10X PCR Buffer

D-8187

Sigma

5 µL

dNTP Mix

-

-

1 µL

Primer 1

-

Invitrogen

1 µL

Primer 2

-

Invitrogen

1 µL

D-8187

Sigma

2 µL

Jump Start Taq Polymerase

REVERSE TRANSCRIPTION PCR MIX
Component

Product No.

Company

Amount
(Per Sample)

rtMM

-

-

49 µL

cDNA

-

-

1 µL

QUANTITATIVE PCR REACTION MIX FOR bGPx
Component

Product No.

Company

170-8882

BioRad

bGPx Primer 1

-

Invitrogen

1 µL

bGPx Primer 2

-

Invitrogen

1 µL

Autoclaved H2O

-

-

SYBR Green 2X Supermix

Amount (Per Well)
12.5 µL

9.5 µL

QUANTITATIVE PCR REACTION MIX FOR POLY-A
Component

Amount
(Per Well)

Product No.

Company

170-8882

BioRad

Poly-A Primer 1

-

Invitrogen

1 µL

Poly-A Primer 2

-

Invitrogen

1 µL

Autoclaved H2O

-

-

SYBR Green 2X Reaction Mix
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12.5 µL

9.5 µL

QUANTITATIVE PCR MASTER MIX FOR bGPx (bGPxMM)
Component

Amount
(Per Gene)a

Product No.

Company

170-8882

BioRad

bGPx Primer 1

-

Invitrogen

41 µL

bGPx Primer 2

-

Invitrogen

41 µL

Autoclaved H2O

-

-

SYBR Green 2X Reaction Mix

512.5 µL

389.5 µL

a

Analyzing 41 reactions (3 wells per calf/calibrator/NT + 1 per calf/calibrator/NT)
Note: Add an additional reaction to each calf/calibrator/NT to ensure enough in case
of pipetting error.

QUANTITATIVE PCR MASTER MIX FOR POLY-A (PaMM)
Component

Amount
(Per Gene)a

Product No.

Company

170-8882

BioRad

Poly-A Primer 1

-

Invitrogen

41 µL

Poly-A Primer 2

-

Invitrogen

41 µL

Autoclaved H2O

-

-

SYBR Green 2X Reaction Mix

512.5 µL

389.5 µL

a

Analyzing 41 reactions (3 wells per calf/calibrator/NT + 1 per calf/calibrator/NT)
Note: Add an additional reaction to each calf/calibrator/NT to ensure enough in case
of pipetting error.

QUANTITATIVE PCR MASTER MIX FOR EACH SAMPLE/CALIBRATOR/NT
(MMsamp)
Component

Amount
(Per Sample)

Product No.

Company

bGPxMM or PaMM

-

-

96 µL

cDNAa/calibrator/H2O for NT control

-

-

4 µL

a

1:10 dilution of cDNA was used for all samples and calibrator.
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